Training Programs
NAVBO currently lists 93 Training Programs within the United States that either directly or indirectly relate to the field of vascular biology. The programs are divided by regions within the United States. More are always being added - bookmark this page and check back often.
Currently listing programs from Beth Israel Deaconess Medical Center, Boston University, Brigham & Women's Hospital, Brown University, The Children's Hospital of Philadelphia, Columbia University, Harvard Medical School, Icahn School of Medicine at Mount Sinai, The Johns Hopkins University, University of Massachusetts, University of Pittsburgh, Schepens Eye Institute, Temple University and Yale University
Director:
Mark K. Eskandari, MD, F.A.C.S.
The James S. T. Yao, MD, PhD, Professor of Vascular Surgery
Chief and Program Director, Division of Vascular Surgery
Northwestern University
Feinberg School of Medicine
676 N. St. Clair, #650
Chicago, IL 60611
Contact:
Marsha Blunt, VSSTP Program Coordinator
Telephone: (312) 926-7775
Northwestern Email: marsha.blunt@nm.org
https://www.surgery.northwestern.edu/divisions/vascular/research/scientist-training.html
Program Scope and Mission – The NIH-funded Vascular Surgery Scientist Training Program at Northwestern University is a two-year mentored research training program designed for surgical residents (MD/DO) in general, cardiac, and vascular surgery interested in vascular biology or vascular biomedical engineering careers. Our goal is to provide a seamless multidisciplinary environment in which the trainee may interact with a diverse group of distinguished research faculty. The T32 mechanism provides a stipend, tuition, fees for coursework, travel funds, and health insurance.
The key to this program is an individualized training plan developed by the mentor and trainee. The unique multidisciplinary environment provides trainees with opportunities to work with mentors from different disciplines. The goal of this program is to match the research interest of the trainee to mentors, coursework, seminars, meetings, and a research plan that will collectively provide the experience necessary to launch a successful career as a physician scientist. Trainees may select one of several tracks of study or a combination of tracks:
• Vascular biology with a basic science or translational emphasis,
• Clinical outcomes/health services research
• Biomedical devices in partnership with the Biomedical Engineering Department
• An integrated program designed by the trainee and his/her mentors.
Trainees who select the clinical outcomes/health services research track will pursue the Master of Science in Health Services and Outcomes Research degree program at NU.
Candidates must hold either an MD or DO degree and must have completed at least two years of clinical training prior to enrolling in the program. Candidates must be U.S. citizens, noncitizen nationals, or have been lawfully admitted for permanent residence at the time of appointment. Minorities and women are encouraged to apply. Applicants will submit a written application along with three letters of recommendation.
Director:
Frank W. LoGerfo, M.D.
William McDermott Distinguished Professor of Surgery
Email: flogerfo@bidmc.harvard.edu
http://www.bidmc.org/Centers-and-Departments/Departments/Surgery/Research/Vascular-Surgery/Frank-LoGerfo-and-Leena-Pradhan-Nabzdyk.aspx
Contact:
Leena Pradhan-Nabzdyk, Ph.D., M.B.A.
Instructor in Surgery
Harvard Medical School
Beth Israel Deaconess Medical Center
Vascular Surgery Research-East Campus
330 Brookline Ave. Dana 805
Boston, MA 02215
Email: lpradhan@bidmc.harvard.edu
Website: http://www.longwoodvascularsurgery.com/training.htm
Program Scope and Mission – The Harvard-Longwood Research Training in Vascular Surgery Program is designed to provide two years of intense basic research training in cardiovascular surgery for academic clinicians. The training program addresses the absence of adequate research training for cardiovascular surgeons as it applies to specific areas of clinical disease. This program is fully funded by the National Institutes of Health.
Research training in molecular and cell biology, biomechanics, coagulation and thrombosis, and angiogenesis is provided with a focus on clinically relevant problems such as artherogenesis, intimal hyperplasia, prosthetic/host interactions and thrombosis. Trainees pursue a program of intense research design, ethics, statistics, and evaluation of published research. Trainees carry out their own research projects under the guidance of a faculty mentor. (They are not involved in any clinical activities unless research related.) Laboratory training can be supplemented by graduate level training at Harvard Medical School and Harvard’s Faculty of Arts and Sciences, with course selection complementing laboratory endeavors. Upon completion of the program, trainees are capable of independent research and possess the scientific and research background needed to obtain competitive grants; they have the abilities and knowledge necessary to provide translational expertise as they join medical school faculties.
Director:
Dr. Martin Pollack, M.D.
Professor of Medicine
Email: mpollack@bidmc.harvard.edu
Website:https://www.hms.harvard.edu/dms/bbs/fac/Pollak.php
Contact:
Nephrology Fellowship Program
Catherine Nadir, Fellowship Administrator
Libby Building – West Campus
171 Pilgrim Road – Libby 2
Boston, MA 02215
P: 616.632.9898
F: 617.632.9909
Email: cnadir@bidmc.harvard.edu
Website: https://www.bidmc.org/medical-education/medical-education-by-department/medicine/medicine-fellowships/nephrology-fellowship
Program Scope and Mission – The Beth Israel Deaconess Medical Center (BIDMC) Division of Nephrology is dedicated to providing the highest-quality care to patients, advancing nephrology research and training future physicians and investigators to become leaders in the field. Decades before Boston's Beth Israel and New England Deaconess hospitals came together as Beth Israel Deaconess Medical Center; each was a leader in health care with a long history of personalized patient care and community service. In 1996, the two hospitals merged to form BIDMC. Today, with nearly three quarters of a million patient visits each year in and around Boston, BIDMC is rated among the top hospitals in the country in patient care and National Institutes of Health funding. Like BIDMC, the Division of Nephrology has a rich and remarkable history, boasting an impressive lineage of members and leaders.
Our educational programs are among our program's greatest strengths. Our faculty is recognized locally, nationally and internationally for their excellence in medical education. They serve as core educators in our fellowship program, BIDMC's Internal Medicine Residency Program and at Harvard Medical School. Our educational mission is to train the future leaders of nephrology. The nephrology training program at BIDMC offers a dynamic mix of clinical care as well as basic and translational research, using novel educational approaches in a warm and nurturing environment. Whether our trainees provide superlative care, perform clinical or laboratory research or take on educational roles, our fellowship program provides the tools necessary to chart the future of our specialty.
Director:
Dr. Murray A. Mittleman, Dr.P.H., M.D., D.Ec.
Professor of Epidemiology
Associate Professor of Medicine
Email: mmittlem@hsph.harvard.edu
Website:https://www.hsph.harvard.edu/murray-mittleman/
Contact:
Jacquelynn White
Program Coordinator
Email: jdwhite@bidmc.harvard.edu
Website: https://www.bidmc.org/medical-education/medical-education-by-department/medicine/medicine-fellowships/cardiovascular-medicine-fellowship/research-training
Program Scope and Mission – The past two decades have brought miraculous advances in the field of cardiovascular medicine. At Beth Israel Deaconess Medical Center — a major teaching hospital of Harvard Medical School — our physician-scientists have been deeply engaged in making progress and saving lives.
We offer our fellows the opportunity to play a role in breakthroughs across the spectrum of research and clinical care: predictive medicine, molecular biology, translational research, new technologies, novel therapies, innovative care delivery systems and outcomes research. We invite you to explore whether our program is right for you. Welcome.
Director:
Vasan Ramachandran, MD
Contact:
Mike Galatis
Section Administrator
Section of Preventive Medicine & Epidemiology| Department of Medicine
801 Mass Ave, 4th floor | Boston, MA 02118
Office: (617) 638-8009
Phone: 617-638-8009
Email: mgalatis@bu.edu
Website: http://www.bumc.bu.edu/preventive-med/t32-multidisciplinary-training-program-in-cardiovascular-epidemiology
Program Scope and Mission – The Multidisciplinary Training Grant (T32) in Cardiovascular Epidemiology is a training awarded by the National Heart, Lung, and Blood Institute. Trainees will focus their 2-year training on the epidemiology of cardiovascular disease such as coronary heart disease, stroke, heart failure and other forms of vascular disease, following one of the training pathways: statistical genetics and genomics, computational biology and bioinformatics, or clinical epidemiology.
This position is a postdoctoral training opportunity paid a stipend, and the successful individual will be engaged in a temporary and a defined period (2-year) of mentored advanced training and professional development following completion of a doctoral degree program.
Co-Directors Hematology Training Program:
Kevan Hartshorn - Director, Fellowship Program in Hematology/Oncology
Email: kevan.hartshorn@bmc.org
Adam Lerner
Email: adam.lerner@bmc.org
Contact:
Martin H Steinberg
Professor of Medicine, Pediatrics, Pathology and Laboratory Medicine
Boston University School of Medicine
72 E. Concord St.
Boston, MA 02118
Phone: 617-414-1020
Fax: 617-414-1021
Email: mhsteinb@bu.edu
www.bu.edu/sicklecell
Program Scope and Mission – The Boston University-Boston Medical Center Training Program in Blood Diseases and Resources” is a training program in hematology research that has been active at Boston Medical Center since 1980, currently supporting four pre-doctoral and four post-doctoral trainees/year. The objective of this training program is to provide training in hematology research to graduate students and PhD, MD, or MD, PhD post-doctoral trainees who work with any of 21 faculty. Our program faculty carry out hematology-related research in four areas: Hemoglobinopathies, Platelet and Thrombosis Biology, Hematopoiesis, and Lymphoid Cell Signaling and Immunopathology. We offer a rich research environment for trainees interested in hematology-related basic science, translational or clinical research projects. Among the research resources in hematoloic diseases available to trainees are the Boston University Center of Excellence in Sickle Cell Disease, the Center for Regenerative Medicine and the Amyloidosis Center. One of the strengths of the program is regular interaction at weekly Journal Clubs and Work Seminars between supported doctoral students, post-doctoral fellows and physicians carrying out their hematology fellowships. At the weekly Hematology Grand Rounds, talks are given by outside hematology researchers and such experts are made available to meet with trainees. Doctoral students enter the after having matriculated in variety of doctoral programs, including Biochemistry, Biology, Biostatistics, Microbiology, Molecular Medicine, Pathology and Pharmacology. A clinical research track is now offered to physicians who wish to obtain training in hematology-related clinical research.
Director:
David H. Farb
Contact:
Richard Wainford, PhD, FAHA
Associate Professor
Department of Pharmacology, Boston University
Email: rwainf@bu.edu
Program Scope and Mission – Of the 61 appointees to the Biomolecular Pharmacology Training Grant in the last 15 years, 87% earned the Ph.D. degree. The average time-to-degree has been 5.2 years for the 20 most recent graduates enrolled since September 2007. The current professional positions of graduates in the last 15 years reflect the diversity of opportunities available for Ph.D.s with expertise in pharmacology.
There are three points of entry into the Biomolecular Pharmacology training program: PhD in Pharmacology, PhD in Biomedical Engineering, and PhD in Neuroscience. For more information visit the website. https://www.bumc.bu.edu/busm-pm/programs/
Director:
Katya Ravid, D.Sc.
Professor of Medicine and Biochemistry
https://www.bumc.bu.edu/busm/profile/katya-ravid/
700 Albany St Ctr for Adv Biomed Res
Phone: (617) 638-5053
Email: kravid@bu.edu
Website: http://www.bumc.bu.edu/cardiograd/
Contact:
Executive Assistant: Robin MacDonald
BU Interdisciplinary Biomedical Research Office
Phone: 617-638-5052
Email: remac@bu.edu
Research: http://www.bumc.bu.edu/ravidlab/
Program Scope and Mission – Cardiovascular diseases represent the major causes of mortality and morbidity in the United States, and thus calls for major efforts in fundamental research. The training program, supported by the National Heart Lung and Blood Institute (NHLBI), provides a format for the training of future scientists who will devote time and efforts in developing the tools to study and control the disease.
This program was initiated by Dr. Katya Ravid in 2003, inspired by Drs. Peter Brecher and the late Carl Apstein, prominent investigators and mentors in the field of Cardiovascular Biology. Training is offered to graduate students in topics related to cardiovascular disease, including atherosclerosis heart failure and hypertension, with application of disciplines such as, physiology, pharmacology, biochemistry, molecular biology and genetics. Trainees participate in various activities of the Whitaker Cardiovascular Institute (CVI) at our institute. The training faculty is affiliated with basic science departments and with the CVI. Each faculty has experience in teaching graduate courses, most have had numerous trainees that have gone on to hold academic positions, and all have at least one active grant from NIH. The program may be unique in that it provides an opportunity to train pre-doctoral fellows (PhD students and MD/PhD students) in translational and basic cardiovascular research in an academic setting in which considerable experience is available, where cutting-edge funded research in cardiovascular biology is ongoing, and where sensitivity to the need of graduate students is provided by an academic mentor approach.
Director:
Victoria Bolotina, Ph.D.
Professor of Medicine, Physiology, and Biophysics
Email: bolotina@bu.edu
http://www.bumc.bu.edu/busm-pm/faculty/faculty-profiles/bolotina/
Contact:
Nancy Clinton
Whitaker Cardiovascular Institute
Email: nclinton@bu.edu
Website: http://www.bumc.bu.edu/wci-training-programs/home-2/
Program Scope and Mission – This program is unique, as it offers multidisciplinary state-of-the-art resources, advanced expertise of leading experts in the field, and professional guidance to a highly qualified and motivated group of post-doctoral fellows who want to pursue successful carriers in cardiovascular science. The program has developed a highly interactive research and training environment with successful collaborative initiatives which represent major fields of cardiovascular biology. Our mentors are the leading experts in the following fields:
• Vascular Biology
• Cardiology
• Diabetes and Obesity
• Basic Science
• Clinical Science (Translational Research)
• Regenerative Medicine
• Pulmonary
• Pharmacology
Director:
David J. Salant, M.D.
Chief, Section of Nephrology
Professor of Pathology and Laboratory Medicine
Email: David.Salant@bmc.org
https://www.bumc.bu.edu/busm/profile/david-salant/
Contact:
Dr. Craig Gordon
Director of Training Program in Nephrology
Boston Medical Center, Renal Section
650 Albany Street 5th Floor, Rm 504
Boston, MA 02118-2393
Email: cgordon2@bu.edu
Phone: (617) 638-7330
Website: http://www.bumc.bu.edu/renalsection/overview/
Program Scope and Mission – The Renal Section offers comprehensive clinical and research training. The training programs are supervised by a large full-time staff, which currently includes 21 nephrologists and medical scientists, as well as several associate research training faculties. The size of the staff allows for broad coverage of the various clinical and research areas of nephrology. It also provides intensive supervision of fellows during both clinical and research training. Most fellows are physicians who have completed their training as the basis for a career in academic nephrology. For these individuals, a comprehensive fellowship program includes one year of clinical training in nephrology, usually but not necessarily taken first, and two or more years of research training. Other physician-trainees, anticipating a career in clinical nephrology, take the year of training in clinical nephrology followed by a year or more of training in clinical investigation.
Training positions are also open to medical scientists with a Ph.D. degree who wish to receive post-doctoral fellowship training in aspects of physiology, molecular and cell biology, immunology and clinical research related to the kidney or its diseases. In addition, close ties have been established with basic scientists in other departments and sections of the Department of Medicine, which affords fellows the opportunity of training in molecular biology and basic immunology.
Director:
Gordon H. Williams, MD
Contacts:
221 Longwood Avenue
Boston, MA 02115
Phone: 617-525-7288
Fax: 617-277-1568
Nathalie Serber
Fellowship Program Coordinator
Email: nserber@bwh.harvard.edu
Ole-Petter R. Hamnvik, M.B. B.Ch., B.A.O., M.M.Sc.
Fellowship Program Coordinator
Email: ohamnvik@bwh.harvard.edu
Program Scope and Mission – A vibrant post doctoral Training Program in cardiovascular endocrinology and the cardiovascular and renal aspects of hypertension and diabetes mellitus has existed at Brigham and Women’s Hospital (BWH) (and its predecessor, Peter Bent Brigham Hospital) for over 50 years with an expansion a decade ago to include Morehouse School of Medicine. The Training Program’s continued success has been built on four premises: 1) dedicated trainers committed to the concept of long term effective mentoring; 2) creative mentees dedicated to establishing a lifelong career as biomedical scientists; 3) a pool of junior scientists committed to developing careers as mentors; 4) a dynamic and flexible group of knowledgeable scientists, external to the Core faculty and willing to serve as co-mentors, with expertise in disciplines critical for the career development of mentees. The expertise represented by our faculty members is far-reaching and diverse, including: pathophysiology of hypertension and of vascular diseases in diabetes mellitus, non-renal aspects of aldosterone action, pregnancy-induced hypertension, interventional nutrition, ion transport mechanisms, human genetics, regulation of gene expression, functional genomics, the molecular biology of the vasculature, the physiologic, molecular and cellular biology of veins and arteries, the effect of ethnicity and sex on vascular function and hypertension, regulation and function of natriuretic hormones, and regulation of the renal circulation and electrolyte handling. The disciplines represented are cardiology, endocrinology, nephrology, surgery, genetics, physiology, radiology, neurology, and cell and molecular biology. The techniques include human and intact animal cardiovascular function, ex vivo vascular function, immunology, development of genetically engineered mice, molecular and cell biology, quantitative assays for assessment of hormones and transduction and ionic factors. Finally, our program’s singular focus is the amalgamation of committed, established biomedical scientists with mature, highly motivated trainees to facilitate the mentees obtaining the tools and learning the concepts of biomedical science. Thus, the three-fold goal of this program is to provide a training experience that will allow the trainee to: create and perform independent research; obtain financial support for that research; and develop the tools necessary to be an effective mentor.
Director:
Elizabeth Harrington, Ph.D.
Professor of Medicine, Associate Dean for Graduate and Postdoctoral Studies
Brown University
Email: elizabeth_harrington@brown.edu
Website: https://vivo.brown.edu/display/eoharrin
Contact:
Tim Harrigan
Grant Administrator
Email: tim_harrigan@brown.edu
P: 401-863-1614
Program Scope and Mission – The Brown Respiratory Research Training Program (BRRTP) is a T32 grant with an overall objective the training of physicians and scientists who will become independent investigators in the pathobiology of respiratory diseases and in the health services, outcomes, and epidemiology of these diseases. This will be accomplished by a rigorous program of didactic and career development training and mentored research experience in a collaborative, multidisciplinary setting. The BRRTP aims to bridge gaps between biomedical, behavioral and public health disciplines to advance knowledge regarding how best to reduce disease burden among patients with diseases that affect the respiratory system. The program supports a total of 4 graduate students and 4 postdoctoral trainees per year.
Nominations are being accepted through December 14, 2018 for grant support for one new graduate (PhD) student and two new postdoctoral trainees (MD, PhD, or MD/PhD) in the upcoming program year, which starts on February 1, 2019. Trainees will be supported for up to 2 years of research training. Full details and application information are available on our website.
Director:
Robert J. Levy, MD
and
Joseph W. Rossano, MD
Contact:
Susan Kerns
Email: kernss@ chop.edu
Program Scope and Mission – Forefront National Institutes of Health (NIH)-sponsored postdoctoral research training is offered in three specific areas: Cardiovascular Pharmacology and Gene Therapy; Cardiac Development; Cardiovascular Pathophysiology. A collaborative training program is offered involving participation of leading scientists at the Children’s Hospital of Philadelphia, and the Perelman School of Medicine at the University of Pennsylvania. Examples of ongoing research directions include: Tissue Engineering, Cardiac Development, Biomaterials, Nanoparticles, Gene Therapy for Vascular Injury, and for Cardiac Arrhythmias. Opportunity to participate in clinical research training for CHOP clinical Fellows via enrollment in the University of Pennsylvania Masters of Science in Clinical Epidemiology or other Masters degree programs is available. This program has successfully recruited under-represented minority scholars, and seeks to expand this dimension.
Director:
Jahar Bhattacharya, MD, DPhil
Email: jb39@cumc.colulmbia.edu
Contact:
Admin Manager
Rashmi Patel
Phone: (212) 305-7310
Fax: (212) 305-6701
Email: rmp2105@cumc.edu
Website: http://www.cumc.columbia.edu/pulmonary/research/bhattacharya-lab
Program Scope and Mission – The purpose of this T32 training program (Columbia University Training Program in Lung Science) is to provide an opportunity to promising post-doctoral individuals of exceptional quality to train in careers in pulmonary research. The program is limited to applicants who hold the MD, PhD or MD/PhD degrees and have a strong interest in research. The central features of the Program include intensive research with participating faculty members and didactic exposure to multiple courses in basic and translational science in pulmonology. Research areas span a wide range of pulmonary disciplines with centers of excellence in Acute Lung Injury (ALI), Lung Development, Asthma/COPD and Lung Vascular Biology. Expertise in biochemistry, cell biology, molecular biology, mouse genetics, biomechanics, and physiology are all well represented by the faculty. Highly experienced investigators provide expertise to fellows in a wide variety of subspecialties, including ALI, Infection and Asthma/COPD. Trainees are selected from a competitive pool of applicants. All trainees thus far have gone on to academic careers in pulmonology.
Director and Contact:
Henry N. Ginsberg, M.D.
Irving Professor of Medicine
Founding Past Director
Irving Institute for Clinical and Translational Research
Columbia University
PH-10-305
630 West 168th Street
New York, NY 10032
Phone: (212) 305-9562
Fax: (212) 305-3213
Email: hng1@cumc.columbia.edu
Program Scope and Mission – The Columbia University Health Sciences Campus provides research training in the broad area of cardiovascular disease and specifically in the area of arteriosclerosis. The program supports eight trainees per year. Trainees must be United States citizens or permanent residents. In addition, applicants/trainees must hold a doctoral degree. Usually, this degree will be an M.D. or Ph.D. but holders of other doctoral degrees are encouraged to applied. Trainees are required to undertake a minimum of two years of training, with three years being the norm.
The training faculty of the program consists of approximately forty faculty from different units throughout the Medical Center. The research interests of this faculty are diverse and encompasses basic, clinical, observational, and applied research. Trainees will work directly with a member of our training faculty. Ideal candidates for obtaining a position in the training program will be those interested in pursuing research careers. We encourage members of underrepresented minority groups to apply to our program.
Principal Investigator:
Wendy K. Chung, MD, PhD
Kennedy Family Professor of Pediatrics and Medicine
Email: wkc15@cumc.columbia.edu
http://www.cumc.columbia.edu/ihn/faculty_/WendyChung
Contact:
Sophia Li Ferry
Email: ssl2133@cumc.columbia.edu
Website: http://www.irvinginstitute.columbia.edu/education/research_train_t32.html
Program Scope and Mission – The TRANSFORM TL1 Training Programs are intended to provide scholars with additional research training to prepare for a research career that can contribute in some meaningful way to understanding risk of disease, improving diagnosis and prevention, and tailoring treatment based on an individual’s variation in genes, environment, and/or lifestyle.
With funding from the NIH CTSA award, the Irving Institute for Clinical and Translational Research seeks to promote high-quality research, enhance the integration of clinical and translational science, and deliver advancements more quickly to the patient community. An integral part of this effort is the TL1 Training Programs. We are recruiting applicants for the following programs:
• Post-Doctoral Fellows (2 year commitment to the program)
• Doctoral students (3 month commitment to the summer program) Eligibility (see website for more details):
• Must be a US Citizen or Permanent Resident
• Must have a Columbia appointment, position, or acceptance letter by the start of the award. We do not offer post-doc appointments nor do we accept students who are not formally enrolled in degree granting programs.
• Must have two interdisciplinary mentors. We can assist with connecting applicants to mentors, if needed. Here are some examples of potential research topics:
• Ecological momentary assessment of stress to identify personalized triggers for atrial fibrillation
• Using genetic profile of breast cancer tissue to target therapy
• N-of-1 trial to assess individualized treatment strategy for hypertension
• Apply machine learning to EHR data to predict individualized risk of hospital readmissions
• Integrating data from wearable devices with neighborhood walkability index to predict cardiovascular risk.
Director:
Andrew R. Marks, M.D.
Chairman, Department of Physiology
Founding Director, Center for Molecular Cardiology
Professor, Physiology & Cellular Biophysics; Medicine
Email: arm42@columbia.edu
http://www.physiology.columbia.edu/marksbio2.htm
Co-Director:
Henry Colecraft Ph.D.
Email: hc2405@cumc.columbia.edu
Website: http://www.physiology.columbia.edu/training.html
Program Scope and Mission – The graduate program in Cellular Physiology and Biophysics includes a training program in Translational Cardiovascular Research. This is an optional program for students interested in pursuing advanced graduate training in cardiovascular biomedical research. It is a unique NIH funded program that also supports post-doctoral fellows.
The training program in Translational Cardiovascular Research is conceived to enhance and ensure the development of cardiovascular scientists who have broad-based knowledge in the fields of Cardiovascular Cell Biology, Biophysics, Genetics and Genomics, Bio- and Tissue-Engineering and Clinical Sciences. The training is based within the Clyde and Helen Wu Center for Molecular Cardiology, the Department of Physiology & Cellular Biophysics, and the Department of Medicine. The Center and the Departments of Physiology and Medicine offer a Cardiovascular Seminar Series and journal clubs, joint laboratory meetings, and retreats, which are designed to encourage collaborations and foster excellence. This component of the Department’s Graduate Program seeks to prepare tomorrow’s cardiovascular scientists and endow them with clinical/pathophysiological insights, developing a group of investigators that is focused upon clinically relevant investigation in matters pertinent to heart and vascular diseases. Applicants may have co-mentors, one with primarily basic science expertise and one with translational/clinical science expertise.
Director and Contact:
Gail K. Adler, MD, PhD, FAHA
Email: gadler@bwh.harvard.edu
Program Scope and Mission – A 2 to 3-year Cardiovascular Endocrine Research Fellowship is available at Brigham and Women’s Hospital, Harvard Medical School, and is designed to prepare bench scientists and clinical/translational scientists for successful research careers in Endocrinology, Genetics, Cardiology, and/or Nephrology. The program investigates genetic and hormonal mechanisms associated with cardiovascular and renal disease in hypertension, obesity and diabetes. Basic scientists receive training in cell, organ and animal physiology, and molecular biology. Clinical scientists receive training in human physiology, pathophysiology, genetics and clinical trials. Genes currently under investigation include: caveolin 1, angiotensinogen, LSD1, striatin, mTORC, ERAP1, beta 2 adrenergic receptor and estrogen receptor beta. Areas of interest include aldosterone and mineralocorticoid receptor mediated cardiorenal and vascular damage, and cardiometabolic diseases associated with complications of pregnancy. A common goal of our translational research group is to understand pathophysiological mechanisms and to develop specific approaches to personalized medicine. Candidates should have a PhD and/or MD and must be a US citizen or permanent resident. This well-established program has been supported by an NIH T32 Training Grant for more than 40 years; salaries are based on the current NIH stipend levels. More than 80% of the graduates have research careers in academia, government or industry.
Contact us for additional information or for an application packet (Ms. Haris Lefteri, Executive Director of the Cardiovascular Endocrine Fellowship program, hlefteri@bwh.harvard.edu). Brigham and Women’s Hospital is an equal employment opportunity/affirmative action employer. Women and Minority candidates are encouraged to apply. Additional details of this program can be provided on request.
Director:
William Pu, MD
Professor of Pediatrics
Director of Basic and Translational Research
Department of Cardiology
Boston Children’s Hospital
300 Longwood Ave
Boston, MA 02115
William.pu@cardio.chboston.org
www.cvrlabs.org
Contact:
William Pu, MD
Professor of Pediatrics
Boston Children’s Hospital
300 Longwood Ave.
Boston, MA 02115
Email: William.pu@cardio.chboston.org
Phone: 617-919-2091
Program Scope and Mission – This T32 program is for postdoctoral (MD, PhD, or MD PhD) trainees interested in cardiovascular biology or pediatric cardiology. Based in the Department of Cardiology at Boston Children’s Hospital and Harvard Medical School, the training program spans the breadth of basic, translational, and clinical research in vascular biology and cardiac biology. Among the program’s faculty mentors are leaders in these fields, including: William Pu; Jane Newburger, Jon and Christine Seidman; Rob Gerszten; Anthony Rosenzweig, Calum MacRae, Timothy Hla, Joyce Bischoff, Geoff and Caroline Burns, Da-Zhi Wang, Kaifu Chen, and Sarah de Ferranti.
The program is committed to developing the next generation of researchers in cardiovascular biology. It is committed to a diverse biomedical workforce, including groups traditionally under-represented in biomedical research.
Contact:
Dr. Eric Rimm or
Dr. Goodarz Danaei
https://www.hsph.harvard.edu/cvdepi/
Application: https://www.hsph.harvard.edu/epidemiology/funding-opportunities/
Program Scope and Mission – The Department of Epidemiology at the Harvard T.H. Chan School of Public Health is pleased to offer an NHLBI-funded T32 pre-doctoral and post-doctoral training slot in our Program in Cardiovascular Epidemiology. This training grant is funding a research and training position to study the effects of behavior, the environment, and global health on CVD. This Program is training both pre- and post-doctoral trainees in the rich academic environment of the Harvard T.H. Chan School of Public Health and affiliated institutions locally and worldwide, bringing together outstanding faculty mentors to provide integrated and interdisciplinary experiences and collaborative interactions, specialized curriculum with core and elective coursework, nondidactic practical career training, individual candidate training plans, and opportunities for translation and policy evaluation.
Under the guidance of the Mentor and co-Mentor and according to the interests of each trainee, training is directed toward investigating effects of both established and novel behavioral and environmental risk factors, their personal and population determinants, and the effective interventions to change them, integrating influences of individual susceptibility and psychosocial, educational, neighborhood, and environmental conditions in both developed and developing nations. Training includes modern methodological and analytical techniques required to study the intersections of Behavior with cardiometabolic diseases, including observational epidemiology and interventions in adulthood, adolescence, and early life; the Environment, including nutrition, airborne and environmental toxins, social risks, and physical (built) environment; and Global Health, including observational epidemiology, demography, comparative risk assessment, and controlled interventions at both individual and community levels.
Director:
Bruce D. Gelb, M.D.
Director Mindich Child Health and Development Institute
Professor of Pediatrics, Cardiology, and Genetics and Genomic Sciences
Email: bruce.gelb@mssm.eu
http://www.mountsinai.org/profiles/bruce-d-gelb
Contact:
Kate Eisenberg
Fellowship Coordinator
Email: kate.eisenberg@moutsinai.org
Website: http://icahn.mssm.edu/departments-and-institutes/medicine/divisions/cardiology/fellowships/fellowship-investigator-track/basic-research-training
Program Scope and Mission – Recognizing that the future of basic cardiovascular research is in molecular approaches, Mount Sinai has made a major commitment towards developing one of the premier programs in the country. Established scientists in specific programs and centers perform cutting edge research illuminating cardiovascular biology and disease and train clinicians and scientists to become future leaders of these fields.
The Cardiovascular Research Institute provides a home for a wide spectrum of investigation ranging from the most basic science to disease-focused and patient-based research. It also links faculty interested in cardiovascular biology and disease across Mount Sinai programs, departments, and campuses. The diversity of the faculty and its collaborative culture fosters a multidisciplinary approach to research problems and provides an important bridge between Mount Sinai's outstanding clinical and basic science departments. The research programs in Molecular and Cellular Cardiology have received substantial funding from the NIH, AHA and ACC. There are myriad opportunities for cardiology fellows to pursue basic and translational research. Fellows participating in the program have been involved in major research efforts in the areas of atherosclerosis, heart failure, transplant biology, cardiac excitation, ion channels, cardiomyopathy, and thrombosis. Fellows take courses in Molecular Biology, Cell Biology, Signal Transduction, Physiology and Neurobiology offered through the Graduate School Faculty of Mount Sinai. Fellows participate in journal clubs and seminars offered by the Brookdale Molecular Biology Center and the Molecular Medicine Program. Typically, fellows have presented the results of their work at the most prestigious international meetings of the American Heart Association, American College of Cardiology and American Federation for Medical Research (formerly AFCR).
Director:
Josef Coresh, M.D.
George W. Comstock Professor
Email: jcoresh@jhsph.edu
https://www.jhsph.edu/faculty/directory/profile/155/josef-coresh
2024 E. Monument Street
Room 2-635, Suite 2-600
Baltimore, Maryland 21287
410-955-0495
Email: coresh@jhu.edu
Website: https://www.jhsph.edu/academics/postdoctoral-training/cardiovascular-disease-epidemiology-training-program/
Contact:
Shoshana Ballew, PhD
Assistant Program Director
Email: sballew1@jhmi.edu
Program Scope and Mission – Established in 1975, the Cardiovascular Disease Epidemiology Training Program focuses on interdisciplinary training on the epidemiology of the leading cause of death in the United States. The program integrates knowledge on all aspects of cardiovascular disease: biology, behavior, treatment and prevention. Training emphasizes active participation in research and translational epidemiology using a collaborative approach, which is enhanced by the close relationships between the Department of Epidemiology and the clinical departments of the Johns Hopkins School of Medicine at the Johns Hopkins Hospital. A number of large ongoing cohort studies and clinical trials provide a rich environment for the conduct of research. The main didactic course focuses on risk factors for cardiovascular disease and strategies for prevention. Seminar-style courses offer a more in-depth understanding of disease pathophysiology and clinical management.
The strengths of the program include the existing depth of interest and expertise in cardiovascular disease epidemiology at the Johns Hopkins Medical Institutions, as well as the enthusiasm, commitment, and experience in training and mentorship of the Program Director (Dr. Josef Coresh), Program Co-director (Dr. Elizabeth Selvin) and program faculty. Many trainees are based in the Welch Center for Prevention, Epidemiology and Clinical Research and are mentored by individuals active in both population-based and clinical research. Among other outstanding collaborations, the program benefits from close ties with the Johns Hopkins University Divisions of General Internal Medicine, Cardiology and Endocrinology.
Director:
Dr. Wendy Post, MD
Professor of Medicine
and
Dr. David A. Kass, MD
Abraham and Virginia Weiss Professor of Cardiology
Contacty:
Wendy Post
Email: wpost@jhmi.edu
For Vascular Biology: Thorsten Leucker, MD, PhD
Email: tleucke1@jhmi.edu
Program Scope and Mission – The Johns Hopkins Pathophysiology of Myocardial Disease T32 program trains post-doctoral fellows in multiple areas of heart and vascular disease, spanning basic science through to clinical translational, population, and bio-informatics/modeling disciplines. Dr. Wendy Post and Dr. David Kass are co-PIs of this program first established in 1974 and running continuously for over 45 years. For further information about the Division of Cardiology T-32 grant and eligibility criteria for interested applicants please see https://www.hopkinsmedicine.org/heart_vascular_institute/cardiovascular-research/johns-hopkins-cardiovascular-training-grant.html
Of particular interest to NAVBO are our opportunities to study vascular biology related themes with faculty from the Division of Cardiology, and other Divisions/Departments in the School of Medicine and Johns Hopkins University. These faculty provide expertise and training opportunities in all aspects of vascular biology with an emphasis on exploring molecular mechanisms of vascular inflammation and thrombosis and translating these findings to the clinical arena. Basic studies of vascular inflammation are applied to patients with conditions such as acute coronary syndrome, SARS-CoV-2 infection, metabolic syndrome, HIV infection, and aging. We are using imaging modalities including positron emission tomography (PET) and magnetic resonance imaging (MRI) to study endothelial cell function and assess vascular inflammation in patients.
In addition, our vascular biology program integrates novel high throughput sequencing technologies, such as single cell RNA-seq, single cell ATAC-seq, ChIP-seq and Hi-C techniques, together with state-of-the-art computational methods and targeted wet lab experiments to discover novel genetic mechanisms for atherosclerotic cardiovascular disease (ASCVD). Our work also focuses on genetic ASCVD mechanisms that affect components of the vascular wall, including endothelial cells, vascular smooth muscle cells, vascular fibroblasts and vascular macrophages. Trainees can learn and apply new genomic technologies and experimental genome editing methods to obtain insights on the physiology and pathophysiology of vascular function and disease.
Program Director:
Dr. Patricia D’Amore, PhD, MBA, FARVO
Department of Ophthalmology at Harvard Medical School
Contact:
Bridget Boles
Program Manager
Email: Bridget_boles@meei.harvard.edu
Program Scope and Mission – The Training Program in the Molecular Bases of Eye Diseases (MBED) is an ongoing postdoctoral training program in the Department of Ophthalmology at Harvard Medical School (HMS) that is aimed at attracting and mentoring talented and motivated basic scientist trainees in the field of vision research. The program includes 40 faculty members who represent a wide choice of research interests and expertise to the trainees in the program. The mentors represent a diversity of relevant disciplines including development, ocular immunology, vascular biology, neurobiology, regenerative medicine, gene therapy, growth factor biology, to name a few. In addition, the research faculty are investigating a number of important ocular pathologies such as age related macular degeneration, glaucoma, retinopathy of prematurity, retinal degenerations, corneal inflammation, wound healing, dry eye and corneal transplantation. This diversity provides a wide selection of training opportunities. The training program seeks to train scientists who will use a range of disciplines to investigate, the cause of blinding diseases with the goal of identifying methods for earlier diagnosis, more effective treatments, means for prevention and eventually to develop cures.
Since the initiation of the program in 1997, the program has trained and mentored 78 trainees, many of who continue in the field of vision research and whose achievements are reflected in their publications and presentation record. The goal of the MBED training program is to provide trainees with expertise in molecular approaches and models as well as an understanding of and the ability to recognize the important clinical and basic research questions facing ophthalmology. The commitment of the faculty to the success of their trainees is evidenced by the quality and success of resulting trainees. The location of the affiliate institutions in Boston provides an outstanding research environment with access to excellent facilities and resources. The program encompasses all aspects of training required to produce an independent and successful vision researcher including: full-time research, didactic courses and mentoring. These are all aimed at educating well qualified trainees in knowledge and understanding of the basic and clinical principles that are key to identifying and solving important ophthalmic problems, instruction in grant and manuscript writing and review as well as presentation skills, and training in the responsible conduct of research.
Program Director:
Steven Houser, Ph.D., Professor of Physiology
Director, Independence Blue Cross Cardiovascular Research Center
Lewis Katz School of Medicine, Temple University
Email: srhouser@temple.edu
Contact:
Patricia Parker
Independence Blue Cross Cardiovascular Research Center
3500 N. Broad Street, 10th Floor
Philadelphia, PA 19140
215-707-4045
Email: patricia.parker@temple.edu
Website: https://medicine.temple.edu/departments-centers/research-centers/cardiovascular-research-center/educational-programs
Program Scope and Mission – The Independence Blue Cross Cardiovascular Research Center (CVRC) is a consortium of basic and clinical scientists with a broad mission to develop new knowledge that will lead to better understanding of the causes of cardiovascular diseases. The CVRC facilitates multilevel, interdisciplinary collaborations that help target basic research towards clinical challenges and enables translation of discoveries into novel approaches for the detection, treatment and prevention of debilitating cardiovascular disorders.
• Cellular and molecular bases of human heart failure
• Pathophysiology of cardiac functional remodeling after myocardial infarction
• Biology of proliferative arteriopathy (restenosis and allograft arteriopathy)
• Transplant immunology and allograft vasculopathy
• Atherosclerosis
• Hypertension: Fundamental mechanisms and strategies for reversal
• Stem cells and cardiac repair
• Angiogenesis
• Cardiac hypertrophy
• Immunology and cardiac disease
• Microvascular function in health and disease
• Congestive heart failure
• Metabolic syndrome, diabetes and cardiovascular disease CVRC investigators employ a wide spectrum of in vitro techniques, relevant animal models and patient-based research methods. Research is conducted within a new medical research building at the Lewis Katz School of Medicine. CVRC core laboratories supply investigators with small and large animal models of cardiovascular disease for their studies. Open laboratory space enhances collaboration and the student/fellow experience. The CVRC training program has been and continues to be funded by a T32 training grant awarded by the National Heart, Lung and Blood institute. This funding provides a broad-based, multidisciplinary training experience for pre-doctoral, post-doctoral fellows, and summer medical students in integrative cardiovascular pathophysiology.
Director:
Catarina I. Kiefe, Ph.D., M.D.
Chair and Professor
University of Massachusetts Medical School
Email: catarina.kiefe@umassmed.edu
https://profiles.umassmed.edu/display/130044
Contact:
Richard McManus
Email: Richard.mcmanus@umassmed.edu
Website: https://profiles.umassmed.edu/display/130044
Program Scope and Mission – The University of Massachusetts Medical School (UMMS) has a cardiovascular T32 training grant entitled "Transdisciplinary Training in Cardiovascular Research" under the direction and senior leadership of Drs. Catarina Kiefe and John Keaney. The program represents a wonderful opportunity for the institution to promote the entire spectrum (T0 – T2+) of cardiovascular research on the UMMS campus. A call has been issued to request applications from trainees who wish to become part of this exciting program at the post-doctoral level. New trainees will join four other current trainees in the program.
Eligibility: Please see http://grants.nih.gov/grants/guide/pa-files/PA-14-015.html Applicants must show evidence of high academic performance in the sciences and commitment to a career as an independent researcher. Post-doctoral candidates must have received a PhD, MD, DO, DC, DDS, DVM, OD, DPM, ScD, DrPH, DNSc, PharmD, PsyD, or equivalent doctoral degree from an accredited domestic or foreign institution. By the time of the award, the individual must be a citizen or a non-citizen national of the United States or have been lawfully admitted for permanent residence (i.e., possess a currently valid Permanent Resident Card USCIS Form I-551, or other legal verification of such status). This fellowship program may not be used to support the clinical years of residency training. However, these awards are appropriate for the research fellowship years of a residency program. Research clinicians must devote full-time to their proposed research training and confine clinical duties to those activities that are part of the research training program.
Director:
Akira Sekikawa, MD, PhD
Email: akria@pitt.edu
Co-director:
Emma Barinas-Mitchell, PhD
Email: barinas@edc.pitt.edu
Website: http://www.cvdtraining.pitt.edu/
Program Scope and Mission – This NHLBI-funded T32 program addresses the critical need to promote epidemiological research of cardiovascular disease (CVD). The primary goal is to train individuals in CVD Epidemiology based on a pathophysiological understanding and experiential learning to develop better prevention strategies in future. Our program offers multiple opportunities to pursue training related to CVD in a variety of areas including vascular aging, high risk and international populations, women’s health, nutrition and environment, physical activity and psychosocial factors, grounded in traditional and novel epidemiological and analytical methods. We emphasize Big Data including electronic health record and omics, Mobile Health and Cross Cohort Collaboration. The program current funds four pre-doctoral and 2 post-doctoral trainees.
Director:
Patrick J. Pagano, Ph.D., FAHA
Professor & Vice-Chair for Graduate Education
Department of Pharmacology & Chemical Biology
Molecular Pharmacology Program
Vascular Medicine Institute
http://www.vmi.pitt.edu/faculty/pagano.html
Contact:
Ms. Shannon Granahan
Coordinator, Molecular Pharmacology Program
BST Starzl Tower: W1340
University of Pittsburgh School of Medicine
Pittsburgh, PA 15261
Email: phgradst@pitt.edu
Website: http://www.pharmacology.us/MPTP
Program Scope and Mission – Molecular Pharmacology is a basic science into the molecular exploration of fundamental cellular processes in normal physiology and in disease. The Molecular Pharmacology Training Program (MPTP) of the University of Pittsburgh is a comprehensive, interdisciplinary program that provides research training in the basic and translational aspects of Pharmacology. The MPTP offers formal training through coursework and provides research opportunities individually tailored to suit each student. The program is outstanding in its long-term innovations in training students to be critical thinkers and leaders in their career track of choice as well as to complete their dissertation in a timely manner. The Pharmacology Training Program T32 provides up to 2-years of support in a wide range of disciplines ranging from cardiovascular disease to cancer therapy, neuropharmacology and GPCR receptor signaling.
Director:
Mark Gladwin, MD
Vascular Medicine Institute
University of Pittsburgh
Phone: 412-383-5853
Fax: 412-648-5980
Contact:
Katie Nauman
Academic Administrator
Department of Medicine
Division of Cardiology, E1150 BST
200 Lothrop Street
Pittsburgh, PA 15261
Phone: 412-624-7987
Fax: 412-648-5980
Email: naumanke@upmc.edu
http://www.vmi.pitt.edu/T32.html
Program Scope and Mission – Biomedical investigators are experiencing a limitation in their collective ability to translate the remarkable basic science discoveries of the current era into the clinical arena—a divide appropriately termed “the valley of death.” In our first cycle of funding, we developed a novel training program in bench-to-bedside research methodology designed to train the next generation of clinical and basic researchers in translational approaches to pulmonary vascular biology and medicine. In an effort to address the increasing pressure from the NIH, political leaders, and the public to translate basic discovery into therapeutic applications that positively change lives, we have recently extended the scope of our program to incorporate entrepreneurial training, including:
1) development of a novel joint University of Pittsburgh (ranked #5 in NIH funding)-Carnegie Mellon University MBA Program (ranked #1 in part-time programs) in Entrepreneurship;
2) elective rotations focused on commercialization of biotechnology; and
3) an expanded faculty that includes translational scientist-entrepreneurs.
Director:
Flordeliza Villanueva, MD.
Contact:
Katie Nauman
Academic Administrator
Department of Medicine
Division of Cardiology, E1150 BST
200 Lothrop Street
Pittsburgh, PA 15261
Phone: 412-624-7987
Fax: 412-648-5980
Email: naumanke@upmc.edu
http://www.dom.pitt.edu/card/training/T32.html
Program Scope and Mission – Capabilities for biologic imaging at all levels--spanning molecules to man--have evolved to an unprecedented level of sophistication such that we can now visualize anatomic, functional, cellular, and molecular processes heretofore invisible, opening exciting new opportunities to study disease pathogenesis . In order for this ever- growing capacity to "see," to facilitate bedside translation of scientific discoveries, images must understand what questions are important in biomedical research, and conversely, biomedical scientists must be fluent in the imaging technologies that could revolutionize their work. However, there is a paucity of scientists who can comfortably commute between the spheres of imaging science and biomedical research, resulting in a "disconnect" that stymies what should otherwise be a powerful, bi-directionally facilitative, relationship between imaging science and translational research. To close this chasm, our new T32 Program employs an innovative educational paradigm to train future clinical and basic researchers in a broad spectrum of cutting edge, multimodality imaging platforms as they pursue hypothesis-driven research, with a specific emphasis on translational cardiovascular research. While there are T32s focused on traditional cardiovascular imaging tools (e.g., MRI, SPECT, Echo), to our knowledge, no training program comprehensively integrates biological imaging within translational biological and physical sciences. Our post-doctoral trainees (MD or PhD) will acquire "core competencies" in imaging methods spanning molecular to whole organism ("imaging tool kit") and in the conduct of translational research spanning basic to population levels ("translational tool kit') -- accomplished through a co-mentorship structure, with each trainee having one mentor from the imaging sciences, and another from the biomedical science arena. Our training strategy is structured around Individualized Development Plans that emphasize quantifiable outcomes based on abstract presentations, publications, pursuit of career development grants, completion of didactic courses, or completion of Masters Programs.
The Director, Dr. Villanueva, is a cardiologist, imaging specialist, and translational researcher with extensive mentoring experience. In actualizing the reciprocal relationship between imaging sciences and biomedical research espoused by this T32, she has been at the forefront of molecular probe and ultrasound technology development for molecular imaging and therapeutics. Our Training Committee comprises the Director and 3 co-Directors with expertise in basic, translational, and clinical research and training. Our 15 Imaging Faculty embody the full gamut of state-of-the-art imaging technologies, and 16 Biomedical Science Faculty offer multiple levels of translational research topics in cardiovascular medicine. The Program is enhanced by institutional endowments to Cardiology and the Heart, Lung, Blood, and Vascular Medicine Institute (VMI), a rich infrastructure from the Clinical Sciences Translational Institute and Center for Ultrasound Molecular Imaging and Therapeutics, VMI Cores, and interactions with other institutional translational T32s.
Director:
Albert J. Sinusas, MD
Yale University School of Medicine
Section of Cardiovascular Medicine, DANA-3
P.O. Box 208017
New Haven, CT 06520-8017
Office: 203-785-5005
FAX: 203-737-1026
albert.sinusas@yale.edu
Contact:
James Duncan Ph.D.
Diagnostic Radiology
300 Cedar Street
TAC
New Haven, CT 06520-8042
Email: james.duncan@yale.edu
Website: https://medicine.yale.edu/intmed/cardio/ytric/educationandtraining/postdoctoraltraining.aspx
Program Scope and Mission – The training program is focused on providing multi-disciplinary multi-modality training in molecular and translational cardiovascular imaging for highly qualified fellows holding either a MD or/and PhD, in preparation for academic careers as independent investigators in the highly clinically relevant field of cardiovascular imaging. Post-doctoral fellowship training will be 2-3 years in duration. Currently four fellowship slots are available, although this will be expanded to six. There are three primary research focuses in the post-doctoral training, 1) cardiovascular molecular imaging, 2) cardiovascular imaging technologies and analyses, and 3) translational cardiovascular imaging. Applicants will have full access to resources available through the Yale Translational Research Imaging Center (Y-TRIC), including: small and large animal surgical suite, state-of-the-art digital fluoroscopy suite, 3D ultrasound, novel hybrid CZT SPECT 64-slice CT, microSPECT/CT, microCT, and optical imaging, along with other institutional resources, including; PET/CT, and MRI. Participation in ongoing NIH funded projects. Applications are encouraged from clinical, engineering, and basic science departments. Each trainee is assigned a basic and clinical mentor, and participates in group projects, and weekly seminar series. The goal is to train individuals to work in a multi-disciplinary research environment. Applicants are encouraged to visit our website: http://y-tric.yale.edu/.
Simply send a description of your program to sharon@navbo.org. Include contact information and links to your web site.
Currently listing programs from Emory University, Louisiana State University, Medical University of South Carolina, North Carolina State University, University of Alabama at Birmingham, University of Alabama School of Medicine, University of Kentucky, University of Mississippi Medical Center, University of North Carolina, University of Texas, University of Texas Southwestern Medical Center, University of Virginia, Virginia Commonwealth University, Vanderbilt University and Wake Forest University
Director and Contact:
W. Robert Taylor, MD, PhD
Division of Cardiology
Emory University School of Medicine
Email: W.robert.taylor@emory.edu
Program Scope and Mission – We are recruiting postdoctoral research trainees to work in the laboratories of investigators in the Division of Cardiology at Emory University School of Medicine. Several positions are available in basic science and translational laboratories within the Division. All projects involve animal and cell-based model systems to study vascular biology or cardiovascular disease. Trainees will be responsible for designing, conducting and presenting research, as well as participating in appropriate training, seminars and symposiums as required.
Successful candidates will have a strong publication record in peer reviewed journals and a long-term goal of becoming an independent investigator. Due to grant funding restrictions, candidates must meet the following two criteria to be considered: hold a MD, PhD or equivalent degree AND be a United States citizen or green card holder.
Director:
Viola Vaccarino, MD, PhD.
Wilton Looney Chair of Cardiovascular Research
Professor and Chair, Dept. of Epidemiology
Rollins School of Public Health
Professor, Dept. of Medicine, School of Medicine
Emory University
Contact:
Steven Harris, Program Administrator
Department of Epidemiology
Emory University Rollins School of Public Health
1518 Clifton Rd. NE
Atlanta, GA 30322
Phone: 404-727-1020
Email: steven.harris@emory.edu
Website: https://www.sph.emory.edu/departments/epi/centers/t32/index.html
Program Scope and Mission – The Department of Epidemiology at the Rollins School of Public Health, Emory University, is seeking pre- and postdoctoral fellows for a NHLBI-funded training grant (T32) in cardiovascular diseases. The program focuses on broadly defined inequalities in cardiovascular health, including, among others, factors such as race/ethnicity, sex/gender, socioeconomic status, and geographical residence.
Housed in the Department of Epidemiology, the training program is affiliated with several other departments and schools including Public Health, Cardiology, Medicine, Nursing, and the Morehouse School of Medicine. The program combines training in graduate degree programs in the Rollins School of Public Health with multidisciplinary research experiences working with top investigators in cardiovascular sciences from diverse disciplines, from basic sciences to epidemiology, cardiology, genetics, interventions, and health policy. The training follows a mentor-based model with formal didactic work in areas relevant to research in cardiovascular health inequalities (e.g., statistics, epidemiology, social determinants of health, and cardiovascular physiology), and practical training in grantsmanship, research ethics, and career development. Predoctoral Fellows:
· Will be considered among those accepted in the RSPH’s PhD programs: http://www.sph.emory.edu/academics/doctoral-programs/index.html
· Program covers tuition and stipend while in the fellowship program. Postdoctoral Fellows:
· MDs from various backgrounds pursuing a research career in cardiovascular disease, or PhD graduates in epidemiology, behavioral sciences, environmental sciences, health policy, or other relevant disciplines.
· Opportunity to obtain a MS in Clinical Research.
· Program covers stipend for up to two years. Criteria for appointment to the training program will include academic potential, previous experience, research interest in cardiovascular health inequalities, and compatibility with existing mentors. Only U.S. citizens and permanent U.S. residents are eligible for this program.
Director:
Dr. Donald Menick, Ph.D.
Director, Gazes Cardiac Research Institute
Professor of Medicine
Professor of Biochemistry & Molecular Biology
Director, Molecular & Cellular Biology & Pathology Program
Email: menickd@musc.edu
Contact:
Dr. Donald Menick, Ph.D.
Department of Medicine, Division of Cardiology
Medical University of South Carolina
Gazes Cardiac Research Institute
114 Doughty Street, Room 203
Charleston, SC 29403
Email: menickd@musc.edu
Website: http://academicdepartments.musc.edu/cardiotraining/
Program Scope and Mission – Research at the Medical University of South Carolina (MUSC) has rapidly developed over the past 25 years and cardiovascular biology has been a major focus of resource commitment. For FY2011 MUSC investigators received more than $12.7 million of research funding from the NHLBI alone. Since the beginning of this training program in 1977, there has been and continues to be a strong emphasis on the molecular and structural aspects of the entities involved in cellular dysfunction in cardiovascular disease. MUSC provides an exciting environment for creative, committed investigators and trainees interested in cardiovascular function in health and disease.
Postdoctoral and predoctoral positions are supported by the National Institute of Heart, Lung and Blood training grant "Training to Improve Cardiovascular Therapies". Our objective is the training of promising new scientists with backgrounds in physical, chemical and biomedical sciences in mechanisms of cardiovascular diseases and the experimental strategies and technologies necessary for the development of novel molecular therapeutics targeting these diseases. Our aim is to produce outstanding investigators with broad insight into cardiovascular biology and dysfunction capable of making significant contributions to cardiovascular research. Faculty in the training program come from five broad research areas: 1) Molecular basis of cardiovascular development, 2) Mechanisms of cardiovascular development, 3) Cardiac stem cells and regenerative medicine and bioengineering, 4) Cell signaling, and 5) Proteomics. Our faculty is highly interactive in both predoctoral and postdoctoral training, and our postdoctoral students benefit in many ways from an organized graduate program in cardiovascular biology.
Director:
Dr. Marie Davidian, Ph.D.
J. Stuart Hunter Distinguished Professor
Program Co-Director, NHLBI Integrated Biostatistical Training Program for CVD Research
Email: marie_davidian@ncsu.edu
Contact:
Dr. Marie Davidian
Department of Statistics
Email: davidian@ncsu.edu
Website: https://www.stat.ncsu.edu/programs/nhlbi/
Program Scope and Mission – The shortage of skilled biostatisticians equipped to address emerging challenges in this exciting new era of CVD research calls for training that formally integrates (i) in-depth experience in collaboration in a multidisciplinary environment, (ii) mastery of the theoretical underpinnings of statistics required for valid application of sophisticated biostatistical techniques and research on development of new methodology, and (iii) emphasis on communication and leadership skills. The program capitalizes on the long-standing partnership between NCSU and Duke, which provides trainees with the opportunity for outstanding theory and methods training and to work with internationally-known researchers at the forefront of CVD research. Trainees will develop all of these skills through interaction with faculty at both universities, who themselves have a history of inter-institutional collaboration and research and who have extensive experience in training and mentoring.
The training involves formal coursework in the student's home department on foundational statistical theory, including probability, inference, linear and other statistical models, measure theory and advanced probability, and advanced statistical inference; and on statistical methods, including clinical trial design/analysis, longitudinal data analysis, survival analysis, epidemiology, causal inference, machine learning, and high-dimensional data analysis; and exposure at DCRI to fundamental aspects of CVD medicine, working with large, complex biomedical data, and research responsibility and ethics considerations. There is also extensive formal and experiential training in communication and leadership skills at both institutions. Trainees are introduced to DCRI CVD research gradually and will evolve over their tenures to holding substantial collaborative apprenticeships in which they are fully integrated as functioning members of DCRI project teams. The apprenticeships will provide trainees with extensive working knowledge of CVD research, the opportunity to develop collaborative skills, and the recognition of how new biostatistical methods development follows from challenges encountered in the collaborative context. This last point will be emphasized through mechanisms under which statistical methodological challenges arising in trainees' apprenticeships will lead to doctoral dissertation research in biostatistics.
Director and Contact:
Phillip J. Brantley, PhD
Associate Executive Director For Scientific Education
Pennington Biomedical Research Center/LSU
6400 Perkins Road
Baton Rouge, Louisiana 70808-4124
(225) 763-3046
Email: phil.brantley@pbrc.edu
Program Scope and Mission – Pennington Biomedical Research Center in Baton Rouge, Louisiana invites applications for postdoctoral fellowships on their NCCIH Institutional Training. We are seeking MDs or PhDs with biomedical research experience who are interested in conducting basic research into obesity, diabetes, and the use of botanicals to attenuate metabolic syndrome. Eligible Applicants must be a US citizen or green card holder. Evidence of motivation and skills in scientific writing such as publications and grant experience are highly desirable. Fellowships provide up to three years of funding, and include didactic instruction and mentored laboratory based training necessary to establish an independent research career. http://www.pbrc.edu/training-and-education/postdocs/botanical-approaches-to-combat-metabolic-syndrome/
Director and Contact:
Martin E. Young, DPhil
Professor of Medicine
Jeanne V. Marks Endowed Chair of Cardiovascular Disease
Division of Cardiovascular Disease
Department of Medicine
Heersink School of Medicine
University of Alabama at Birmingham
martinyoung@uabmc.edu
Phone (205) 934-2328
https://www.uab.edu/hypertension/education/t32
Program Scope and Mission – Postdoctoral fellowships are available through the Vascular Biology and Hypertension Program at the University of Alabama at Birmingham (UAB), funded by the National Institutes of Health (NIH)/National Heart, Lung and Blood Institute (NHLBI) institutional training grant, T32 HL007457, “Mechanisms of Hypertension and Cardiovascular Diseases.” This T32 Training Program offers multidisciplinary training in fundamental aspects of the pathophysiology of hypertension and related cardiovascular disease, in innovative approaches to the diagnosis and treatment of these conditions and in translating basic and clinical research findings to the population level. The Program offers advanced training in the following thematic focus areas: Basic Science (fundamental training in mechanisms of inflammatory vascular injury and repair and oxidative stress/free radical injury); Translational Science (translation-to-humans, early clinical trials, testing basic science discoveries for clinical applicability) Clinical Science (research to improve knowledge of new therapies, medical applications and clinical interventions), and Population and Data Science (clinical trials to wide-spread evidence-based practice that improves the overall public health). A list of participating T32 faculty mentors and programs is available upon request.
Director:
Jack M. Rogers, PhD
Professor, Department of Biomedical Engineering
Co-Director Jianyi Zhang, MD, PhD
Professor and Chair, Department of Biomedical Engineering
Contact:
Jack M. Rogers
Email: jrogers@uab.edu
Phone: 205-975-2102
University of Alabama at Birmingham
School of Medicine Dept. of Biomedical Engineering
Volker B128
1670 University Blvd
Birmingham, Alabama 35233
Program Scope and Mission – Cardiovascular tissue engineering (CVTE) has tremendous, but as yet unrealized, potential to treat disease. Future scientists and engineers working in this area will need expertise in a broad range of subfields including cardiovascular pathophysiology, cell/scaffold engineering methods, and the diverse technologies needed to evaluate the electromechanical safety and efficacy of prototype therapies. To help meet this need, the NIH National Institute of Biomedical Imaging and Bioengineering (NIBIB) has awarded UAB a new Ruth L. Kirschstein NRSA Institutional Research Training Grant (T32). The five year grant, titled “Development and Functional Assessment of Cardiovascular Tissue Engineering Therapy,” will be co-directed by BME Chair Jay Zhang and myself. The program will support up to four predoctoral students per year drawn from UAB’s Biomedical Engineering and Graduate Biomedical Sciences programs. The new program builds on research strengths in CVTE-related fields in the BME department and across UAB. We are excited and thankful for the new support from NIH and look forward to training a cadre of professionals in academia, government, and industry who will accelerate the safe clinical adoption of CVTE technology.
Contact:
Nancy R Webb, PhD
T32 Program Director
Department of Pharmacology and Nutritional Sciences
Director, Division of Nutritional Sciences
535 Wethington Health Sciences Building
Lexington, KY 40536-0200
Phone: (859) 218-1385
Email: nrwebb1@uky.edu
https://pharmns.med.uky.edu/node/45417
Program Scope and Mission – An NIH-funded T32 training grant entitled “Pharmacology and Nutritional Sciences: Multidisciplinary Approaches for Metabolic Disease” is housed in the Department of Pharmacology and Nutritional Sciences, Division of Nutritional Sciences at the University of Kentucky. The training grant seeks to prepare biomedical scientists for academic careers in research focused on pharmacological and nutritional approaches to prevent and treat metabolic-based disorders. The training faculty come from 8 different departments in 4 Colleges across the University of Kentucky campus. They have expertise in the four theme areas of the training grant: obesity/diabetes, cardiovascular disease, cancer, and neuroscience/aging.
Director:
Susan Smyth, M.D., Ph.D.
Chief, Division of Cardiovascular Medicine
Linda and Jack Gill Heart and Vascular Institute
Director, MD/PhD Program
326 CTW Building 900
900 south Limestone Street
Lexington, Kentucky 40536-0200
Email: SusanSmyth@uky.edu
Website: Clinical Scholars in Cardiovascular Science
Co-Director:
Leigh Ann Callahan, M.D.
Program Scope and Mission – The University of Kentucky Training Program for Clinical Scholars in Cardiovascular Science is designed to prepare exceptional clinical and postdoctoral fellows to assume leadership positions directing multidisciplinary research in the field of cardiovascular medicine. In the last several years, as a consequence of substantial institutional commitment, we have assembled an integrated approach of incorporating basic, translational and clinical cardiovascular science in four concentrations: Thrombosis and Inflammation; Atherosclerosis and Aneurysm; Cardiac Hypertrophy and Heart Failure; and Vascular Cell Response to Stress. Our cardiovascular science strengths to provide a unique multidisciplinary training program that unites trainees across the disciplines of Medicine, Nursing, and Pharmacy with the goal of increasing the pipeline of clinical investigators who will bridge the gap between basic science advances and their application to clinical medicine. Specifically, we aim to:
1) To provide a rigorous and solid research education in the basic sciences related to cardiovascular research
2) To prepare new researchers for translational and clinical science in a highly interdisciplinary environment
3) To provide training in the efficient and ethical conduct of high quality laboratory management and science
4) To create an environment that incubates fellows and mentors with an innovative and nurturing structure of interlaced mentoring teams
The program is available to M.D., M.D./Ph.D., R.N./Ph.D., Pharm.D., and Ph.D.s with clinical emphasis who are at the early post-doctoral stage of their careers. Upon completion of the program, we anticipate that the trainees will have the experience and capabilities necessary to initiate an independent career as clinical investigator.
Director:
Joey P. Granger, PhD
Contact:
Betsy Davis
Director of Research Operations
MS Center for Clinical and Translational Research
University of Mississippi Medical Center
Email: sedavis@umc.edu
Program Scope and Mission – UMMC has identified hypertension and cardiovascular and renal diseases as a major area for research development in its strategic research plan. The institution has made a significant commitment to basic and clinical cardiovascular and renal research and the training of students and fellows at both the pre-doctoral and postdoctoral level. Additionally, UMMC is committed to training students and fellows that are members of under-represented racial and ethnic minorities.
There are several key features of this program:
· Long history of cardiovascular and renal disease research and training at UMMC;
· Only extramurally funded institutional training grant at UMMC;
· Multidisciplinary instruction through a core curriculum and an interdepartmental research center (CRRC) that focuses on hypertension and cardiovascular-renal diseases research;
· Required application for independent pre-doctoral and postdoctoral funding for all trainees;
· Requirement to develop an individual development plan (IDP);
· Unique Career Opportunities and Profession Development (COPD) seminar series for trainees to learn about wide range of career opportunities;
In response to the recent NIH Biomedical Research Workforce report, alternative career modules (teaching, business, and pharma/biotech) for trainees to expand their training experiences are provided;
Outstanding institutional support where Graduate School provides:
· 3 years of stipend support for graduate students
· Full tuition scholarships for all PhD students
· Trainee travel program provides up to $1,500 per academic year for PhD trainees presenting their research at a conference. Graduate students who are awarded an individual extramural fellowship grant are also eligible to receive an additional travel stipend of $1,500 to present their research findings at a national meetings. · Professional skills travel program provides up to $1,500 per academic calendar year for PhD graduate students to attend one workshop, review course, etc. per academic year.
Contact:
Kari North, PhD
Professor and Program Director
Department of Epidemiology
University of North Carolina
137 East franklin Street Suite 306
CB# 7435
Chapel Hill, NC 27599
(919)966-2148
Kari_north@unc.edu
Website: https://sph.unc.edu/epid/epidemiology-research/genetic-epidemiology-research/
Program Scope and Mission – Human genome studies are providing fresh insights into heart, lung, and blood (HLB) traits, with opportunities for translation of research findings to clinical and community settings for disease prevention and health promotion. Yet, there remain an insufficient number of HLB genetic epidemiologists who can design and implement multidisciplinary HLB genetic epidemiology research that combines technological advances in genome measurement with cutting-edge statistical tools to advance understanding of the genomic basis of HLB traits and associated diseases in the most-burdened populations.
The Genetic Epidemiology of Heart, Lung, and Blood Traits (or GenHLB) Training Grant responds to these research gaps by providing interdisciplinary, integrated, and comprehensive instruction in the genetic epidemiology of HLB traits from an outstanding team of research mentors with expertise spanning four proposed training dimensions: HLB genetic epidemiology; computation/methods; `OMICs; and culture, diversity, and disparities. The Training Program will encompass formal didactics based on an individual development plan; tailored mentorship; research experiences in two training dimensions; presentations; manuscript and grant preparation; research seminars and colloquia; and instruction in the responsible conduct of research. The GenHLB training program also will include careful evaluation of the quality and effectiveness of the Training Program, ensuring that fellows achieve the competencies and skills necessary for success as future HLB genetic epidemiology research leaders.
The five-year program aims to support four (two pre-doctoral and two postdoctoral) fellows at initiation, increasing to six (three pre-doctoral and three postdoctoral) fellows in year 03. Among the postdoctoral fellows, prior expertise in epidemiology, human genetics, biostatistics, bioinformatics, computational biology, medicine, and applied mathematics will be sought. Pre-doctoral fellows will be required to pursue a doctoral degree in epidemiology, specializing in HLB genetic epidemiology. Our selection of internationally known research mentors with established research collaborations, unique and multidisciplinary training environment, and unparalleled research opportunities make us exceptionally well-positioned to lead this novel training program and develop the next generation of genetic epidemiology leaders who are well-equipped to investigate the genetic underpinnings of HLB traits and associated diseases.
Director:
Christopher Mack, Director
Associate Professor of Pathology
University of North Carolina
111 Mason Farm Road
Suite 2341 MBRB
Chapel Hill, NC 27599
(919) 996-7126
cmack@med.unc.edu
Website: https://www.med.unc.edu/ivb/
Contact:
Tracy Riley
Contacts & Grants Facilitator
triley@med.unc.edu
Program Scope and Mission – In response to the demands of the post-genomic era, we established the Integrative Vascular Biology (IVB) Pre-doctoral Training Program at the University of North Carolina in 2002 to promote a collaborative interdisciplinary training environment for pre-doctoral students in the cardiovascular field. The IVB Program was founded on the breadth and depth of the cardiovascular research faculty at UNC and institutional strengths in genetic model systems, state of the art cell biology and imaging, high throughput genomic and proteomic analyses, and computational biology. The overall goal of the IVB Program is to provide Trainees with the interdisciplinary and collaborative skills necessary to extend their thesis work into new, innovative, and productive directions. Our primary training faculty are drawn from 12 UNC departments and have specific expertise in heart and blood vessel development, thrombosis and hemostasis, the mechanisms that contribute to atherosclerosis, and the pathophysiology and treatment of myocardial ischemic disease. By requiring trainees to collaborate with secondary mentors outside of their Field, Department, and/or Institution, the program teaches students to apply molecular, cellular, genetic, and computational approaches to pathological and physiological questions in cell, organ, and whole animal systems; to merge hypothesis- and discovery-based research; to develop high-throughput approaches in cardiovascular models, and to translate their work to clinical settings. 
Trainees are exposed to the latest concepts in cardiovascular biology by enrolling in advanced paper-based courses specifically designed for UNC's Graduate Certificate Program In Cardiovascular Science, by attending formal cardiovascular seminars by inside and outside speakers, and by participating in a bi-weekly student-led discussion group. To enhance the skills necessary for effective collaboration and career advancement, Trainees attend program workshops on grant writing, career development, and scientific rigor and responsibility, and they present their data formally at the annual IVB Research Symposium, a trainee-organized event that draws over 120 cardiovascular researchers from the greater Chapel Hill area. In summary, with an outstanding history in cardiovascular research, a strong, well-funded group of investigators centered around the McAllister Heart Institute, a structured academic program in Cardiovascular Science, and institutional excellence in genetic model systems, cell biology, high throughput sequencing, and computational biology, the UNC Integrative Vascular Biology Program offers an outstanding environment for multidisciplinary training of pre-doctoral students. For more information, please contact program Director Christopher Mack.
Director:
Dr. Kytai T. Nguyen
Contact:
The University of Texas at Arlington
Science & Engineering Innovation & Research Building, SEIR-367
655 W. Mitchell St.
Arlington, TX 76010
Phone: 817-272-2540
Website: https://blog.uta.edu/knguyen/
Program Scope and Mission – Nanotechnology and nanomedicine have been developed and used to detect and improve the treatment efficacy for many diseases, including cardiovascular and lung disorders. However, only a few doctoral programs exist to train doctoral (Ph.D.) students to have a background of strong, basic health and translational science in conjunction with new advances in nanotechnology and nanomedicine applied to cardiovascular and lung diseases. To bridge the gap, our long-term objective of this NIH T32 training program is to train doctoral students in North Texas in the principles, advances, opportunities and limitations of nanomaterials, nanomedicine and nanotechnology for use in the detection and treatment of cardiovascular and lung diseases. To reach our objective, we will provide an integrative nanotechnology training program, enhance trainees’ expertise and knowledge in broad-based nanotechnology areas, and achieve outstanding program outcomes in order to raise up the next generation of nanotechnology leaders.
Director and Contact:
Dr. James D. Stockand, PhD
University of Texas Health Science Center
Department of Cellular and Integrative Physiology -7756
7703 Floyd Curl Drive, MSK 7756
San Antonio, TX 78229
Voice 210-567-4332
Email: stockand@uthscsa.edu
Website: http://gsbs.uthscsa.edu/faculty/james-d.-stockand-ph.d
Program Scope and Mission – Cardiovascular disease complications remain the major leading cause of death and disability in the United States and other developed countries. While lifestyle clearly contributes to the development of cardiovascular disease, it has not proven realistic to expect resolution of major morbidities (and attenuate costs) simply on the basis of changes in lifestyle. Consequently, biomedical science must continue to address improvements in the prevention, diagnosis and treatment of the widespread and devastating complications of cardiovascular disease. To achieve this goal, a cadre of well-trained, multidisciplinary scientists, capable of working in investigative teams, is required. This postdoctoral research training program enables the continued achievement of excellence in research training in cardiovascular pathobiology by preparing new investigators with the necessary competencies and breadth of expertise needed for future biomedical research.
This is a multi-disciplinary postdoctoral research training program in cardiovascular science that annually supports six doctoral graduate fellows in medicine, dentistry, veterinary medicine, or the basic biomedical sciences. Program faculty are distributed among twelve academic departments at the University of Texas Health Science Center at San Antonio, and two departments at nearby sister institutions, the University of Texas at San Antonio and the Southwest National Primate Research Center.
Co-Directors:
Lance Terada, MD
Professor and Chief
Pulmonary and Critical Care
Philip Shaul, MD
Vice Chair for Research
Professor and Chief
Pulmonary and Vascular Biology
Contact:
Lance Terada, MD
Lance.terada@utsouthwestern.edu
Websites: http://www.utsouthwestern.edu/education/medical-school/departments/internal-medicine/divisions/pulmonary-critical-care/fellowships/fellowship-tracks.html
Program Scope and Mission – This program provides structured research training opportunities at the postdoctoral level with support for two years of training. The proposal is born out of a collaborative effort between divisions within the Pediatric and Internal Medicine departments involved in lung and vascular research at this institute, and is thus interdepartmental at its core. Our training faculty consist of experienced investigators representing 16 different clinical and basic science departments and centers, forming a solid, diverse training force, organized into four thematic tracks: 1) Pulmonary vascular disease; 2) Interstitial lung diseases; 3) Lung epithelial cell and differentiation disorders; and 4) Immunity/Inflammation/Sepsis. Besides mentor-based teaching, trainees will receive a comprehensive track- and project-specific didactic curriculum. Both clinical and basic science trainees will be guided by an individualized advisory committee that has both basic and clinical science mentors, to broaden the trainee’s perspective and facilitate bench to bedside thinking. Emphasis will be placed on maintenance of project focus, creative experimental design, state of the art technology, and careful early career guidance.
Director and Contact:
Mark D. Okusa, MD
1300 Jefferson Park Avenue
West Complex, Room 5097B
University of Virginia Health System
Charlottesville, VA 22908–0133
Voice 434.924.2187
Email: Mdo7y@virginia.edu
Website: https://med.virginia.edu/nephrology/research/t32-training-grant/
Program Scope and Mission – Kidney disease is a major health problem for both adults and children. Renal diseases of various etiologies continue to grow at a rate of epidemic proportions. Furthermore there is a diminishing “pipeline” of nephrology trainees leading to a lack of new discoveries, cures and clinical trials in the kidney research arena. It is imperative that we meet this challenge and ensure the training of a new cadre of outstanding investigators in kidney-related research. The goals of the program are to identify promising candidates and train them for careers in academic nephrology. We have assembled an exemplary team of clinician and basic science investigators with an outstanding track record of mentorship from various Departments and Centers including: Medicine, Pediatrics, the Pediatric Center of Excellence in Nephrology, Pharmacology, Microbiology, Molecular Physiology and Biophysics, Biomedical Engineering, the Cardiovascular Research Center, Surgery, the Beirne Carter Center of Immunology and Public Health Sciences. The basic/translational faculty laboratories offer research experience that links kidney development, cell fate, and disease with inflammation. The program provides training and didactic instruction in fundamental and cutting-edge methodologies, including novel molecular, cellular, transgenic and imaging technologies, as well as immunology, functional genomics and novel imaging technologies. The patient- oriented clinical research program provides training in clinical investigation, epidemiology, biostatistics and human genetics. Three new mentors in genetic susceptibility to kidney disease and disease progression have been recruited. Adult and Pediatric Nephrology trainees with M.D. degrees will pursue a program consisting of 1 year of clinical training, which is not supported by the grant, and 2-3 years of research training funded by this application. PhD applicants will be required to have prior research experience and outstanding references. Each of the thirty-four mentors/co-mentors has a track record of mentorship and is an expert in one or more core areas that pertain to kidney development and disease and inflammation including: kidney development and disease pathogenesis, diabetes/vascular disease, cell signaling, leukocyte biology and patient-oriented research/genetic epidemiology. All trainees will be required to attend regular seminars, journal clubs and specific courses addressing research methodologies, experimental design, research integrity, ethics and faculty development, in addition to. Newly designed translational programs are aimed to link clinical disease with basic science. They will be expected to design, conduct, and analyze experiments with progressive independence in our new, modern, and well-equipped laboratories. We value and encourage applicants from diverse academic and ethnic backgrounds. It is the goal of the mentored training program that its graduates attain a strong foundation in translational biomedical research and be among a new generation of academic nephrologists and renal investigators who will make significant contributions in addressing the growing problem of kidney disease in the adult and pediatric populations.
Director:
Gary K. Owens Ph.D.
Email: gko@virginia.edu
Contact:
Mary Thomas
Programs Administrator/Administrative Generalist
Robert M. Berne Cardiovascular Research Center
415 Lane Road (MR5) PO Box 801394
Charlottesville, Va. 22908
Phone: (434)243-9943
Email: mt3kx@virginia.edu
http://training.cvrc.virginia.edu/gradstudents.php
Program Scope and Mission – Despite decades of research there are still fundamental gaps in our knowledge of the underlying mechanisms that contribute to development and progression of most cardiovascular diseases (CVD), as well as the end stage clinical consequences of these diseases and how to better treat or prevent them. Indeed, CVD remains the leading cause of death worldwide. A central premise of our NIH T32 cardiovascular (CV) research training program (CVTP) is that these diseases are extremely complex, and that rigorous study of them requires trainees to have a strong foundation of knowledge of basic CV physiology, developmental biology, genetics, genomics, bioinformatics, epigenetics, pathology, systems biology, biomedical engineering, and many other disciplines. A major strength of our CVTP is that we have >50 outstanding clinical, translational, and basic science mentors representing all of these areas, and we have built a unique training program over the past three decades that integrates mentoring talents into producing the best trained cardiovascular scientists possible. Our goal is to provide pre-doctoral and post-doctoral trainees the necessary knowledge, intellectual capabilities, technical skills, and problem-solving abilities to conduct outstanding state-of-the-art CV research employing a wide range of powerful and innovative approaches.
The program is led by Dr. Gary K. Owens and two talented Associate Directors Drs. Brant Isakson and Shayn Peirce-Cottler who are exceptional CV researchers and mentors. Pre-doctoral trainees are selected from a large pool of outstanding trainees initially recruited into an umbrella biomedical sciences (BIMS) graduate program http://bims.virginia.edu/ or the UVA MD/PhD (NIH MST) Program https://mstp.med.virginia.edu/, whereas post-doctoral candidates are largely recruited by individual mentor labs or from one of several clinical residency-fellowship programs. After completing a highly innovative BIMS 6000 core course in integrated biology in year 01, CVTP pre-doctoral trainees take elective modular courses that are customized based on their interests and degree program. They also complete three lab rotations to aid in selection of a mentor. Only trainees who have already selected a CVTP mentor are eligible for appointment to our NIH T32 training grant. All trainees are required to take our signature CVTP advanced courses including BIMS 8052-3 (Advanced Vascular Biology) and BIMS 8064 (a trainee-run Careers/Professionalism Course), and are also required to attend our weekly research seminars, monthly research in progress sessions, bi-annual research retreats, and to complete biomedical ethics training. The CVTP also has an exceptional grant writing program including an annual workshop and approximately 20 annual grant brewing sessions.
There are many indices of the success of this program including CVTG trainees: 1) publishing many high impact first author papers including in some of the highest rated biomedical journals such as Nature, Nature Medicine, and Circulation Research; 2) having a >50% success rate in securing extramural fellowships upon first submission; 3) securing high quality post-doctoral, or faculty/leadership positions, at major academic medical centers, in the pharmaceutical industry, or with biotechnology companies; and 4) making extraordinary contributions advancing our understanding of the cardiovascular system, as well as developing better ways to treat or prevent CVD.
Director:
Irving L. Kron, M.D.
Professor and Chair of Surgery
Division of Thoracic and Cardiovascular Surgery
Email: ilk@virginia.edu
Website:https://surgery.virginia.edu/tcv-lab/teaching-training/resident-research-training-program/
Contact:
Tony Herring, Laboratory Manager
P.O. Box 801359
Bldg MR4, Rm 3116
409 Lane Road
Charlottesville, VA 22908
Office: 434-924-9297 Fax: 434-924-1218
Email: ajh@virginia.edu
or
Victor E. Laubach, PhD
Professor of Surgery
Office: 434-924-2927 Fax: 434-924-1218
Email: laubach@virginia.edu
https://uvahealth.com/findadoctor/profile/irving-l-kron
Program Scope and Mission – Our TCV Surgery Research Training Program has been continuously funded since 2000 by an NIH T32 Training award with Dr. Irving Kron as the Principle Investigator. This training program provides collaboration between basic scientists and surgical faculty to train academic cardiothoracic surgeons. The main objective of our program is to provide surgery residents with hypothesis-driven research training in laboratory or clinical research in order to foster their development into independent academic translational researchers. Translational research defines the area of overlap between basic and clinical studies, where new therapies, interventions, assays, etc. are brought out of the laboratory for human benefit. The primary discipline which our program focuses on is translational research into vascular and end-organ function following transplantation or surgery.
Director:
Christopher M. Kramer, M.D.
Ruth C. Heede Professor in Cardiology
Director, Cardiovascular Imaging Center
Email: ckramer@virginia.edu
Website:https://med.virginia.edu/faculty/faculty-listing/cmk2n/
Contact:
Lisa Mackey
Cardiovascular Imaging Fellowship Coordinator
UVA Division of Cardiovascular Medicine
1215 Lee Street, Room 2772
PO Box 800662
Charlottesville, VA 22908
Email: lmm7x@virginia.edu
https://med.virginia.edu/cardiovascular-medicine/fellowship-education/advanced-fellowships-in-cardiovascular-medicine/cardiovascular-imaging/
Program Scope and Mission – UVA’s advanced fellowship in cardiovascular imaging trains fellows in the use of cutting-edge technology that in turn facilitates a better understanding of the mechanisms of heart disease and of cardiac physiology and pathophysiology.
Specific program goals include:
- providing competence in technical aspects of imaging;
- providing competence in cardiac physiology and pathophysiology;
- studying and developing innovative methods of imaging The Advanced Cardiovascular Imaging Fellowship Program is supported by a training grant from the National Institute of Biomedical Imaging and Bioengineering (NIBIB).
Director:
Dr. Greg Hundley
Email: Greg.Hundley@vcuhealth.org
Contact:
Megan O’Hare
Program Manager
Pauley Heart Center
Office: 804-628-6609
Email: megan.ohare@vcuhealth.org
Program Scope and Mission – The Pauley Heart Center is seeking candidates for a postdoctoral training program in cardiovascular disease research. This 3 year individually-tailored training program offers a stipend and tuition reimbursement for a VCU Masters in Clinical Health Science program, or other VCU master’s degree program. In addition, travel funds to present at a scientific conference as well as funds for health insurance expenses.
Research opportunities may include laboratory-based, translational and clinical projects, may involve animal or human subjects and relate to cardiovascular disease. Some areas of interest include (but are not limited to):
- Cardiotoxicity related to cancer therapy
- Role of inflammation in acute myocardial infarction and heart failure
- Cardiovascular pathophysiology in the context of metabolic disease
- Mechanisms of myocardial protection in ischemia/reperfusion injury
- Mitochondrial biology as it relates to heart injury and the aged heart
- Nanoengineering novel platforms for therapeutic delivery of miRNA in cardiopulmonary disease
- Molecular and cellular mechanisms of electrical remodeling in diseased hearts
- Development of computational models to study electrical signaling in cardiac electrophysiology
- Preventive cardiology
- Social and behavioral determinants of cardiovascular events
- The impact of obesity in cardiovascular disease
Required Qualifications:
Candidate should have a PhD, MD/PhD or equivalent degree by the start of the fellowship and a commitment to a career in cardiovascular medicine. In addition, candidate should have demonstrated experience working in and fostering a diverse faculty, staff, and student environment or commitment to do so as a postdoc at VCU. MUST have a green card or US citizenship.
Director:
Dr. C. Michael Stein, M.B., Ch.B.
Dan May Professor of Medicine and Pharmacology
Email: michael.stein@vanderbilt.edu
Website: https://wag.app.vanderbilt.edu/PublicPage/Faculty/Details/29060
Contact:
C. Michael Stein, M.B., Ch.B.
542 Robinson Research Building
Email: michael.stein@vanderbilt.edu
Website: https://medicine.mc.vanderbilt.edu/vanderbilt-clinical-pharmacology-fellowship-program-0
Program Scope and Mission – Vanderbilt’s Clinical Pharmacology Fellowship Program is a highly successful program that has produced graduates who are now in prominent positions in academia, industry and regulatory agencies. Our training program is registered with the American Board of Clinical Pharmacology and thus trainees are eligible to sit for the board exam.
The training period is at least 2 years, preferably more, and is weighted towards learning through mentored research. In addition, formal coursework and directed learning provide education in core skills. Trainees include individuals with an M.D., Ph.D. or Pharm.D. degree who are planning a career in clinical pharmacology or a career that will be strengthened by significant exposure to clinical pharmacology. A large and diverse faculty in the division, the rich resources at Vanderbilt and our commitment to training has established the outstanding reputation of this Clinical Pharmacology Fellowship Program. Continued excellence of the program depends on our fellows and we invest heavily in their training.
Contact:
Randi Sullivan, MD, MHS
Administrative Secretary
Wake Forest University School of Medicine
Department of Internal Medicine
Section on Cardiovascular Medicine
Medical Center Boulevard
Winston-Salem, NC 27157
Phone: 336.716.9124
Fax: 336.716.9188
randi.sullivan@wakehealth.edu
Program Scope and Mission – The purpose of the CVD Epidemiology Training Program, a federally-funded National Research Service Award (NRSA) Institutional Research Training Grant (2 T32 HL076132), is to attract and train a cohort of outstanding physician scientists who will be fluent in the latest developments in cardiovascular disease and able to apply this knowledge to the conduct of new cardiovascular epidemiology and clinical cardiovascular research. Key features of the training program include completion of a Master’s Degree in Clinical and Population Translational Science with a curriculum that also includes formal training in molecular biology and genetics, supplemental training in genomics, proteomics and informatics, joint mentorship with both clinical and basic science faculty, and participation in external NHLBI sponsored short courses in cardiovascular epidemiology, and the genetics of complex heart, lung, and blood disorders.
Simply send a description of your program to sharon@navbo.org. Include contact information and links to your web site.
Currently listing programs from BloodCenter of Wisconsin, Northwestern University, Ohio State University, University of Cincinnati, University of Illinois at Chicago, University of Iowa, University of Michigan, University of Minnesota, University of Missouri, University of Wisconsin, Wayne State University, and Washington University Medical School.
Director:
Gilbert C. White, II, MD
Contact:
Attn: Portlynne Joseph/T32 Postdoc
Blood Research Institute
PO Box 2178
Milwaukee, WI 53201-2178
Email: postdoc@bcw.edu
Website: https://www.bcw.edu/bcw/Research/T32Fellowship/index.htm
Program Scope and Mission – Research opportunities available to trainees cover a broad range of basic and clinical research subjects relevant to transfusion medicine and hematology; including; Immunology, Vascular Biology/Hemostasis, Transfusion Medicine, Stem Cell Biology, and Clinical Research. The research training experience will be essentially full time. Trainees will be expected to gain a basic understanding of the disciplines in which they undertake their investigations, develop competency with a variety of research technologies, strengthen their grasp of their chosen research by taking selected courses in the graduate studies program of Medical College of Wisconsin, and develop the ability to conduct independent research. Time spent in fellowship training is regarded as one of several stages of professional development. Accordingly, additional tracks will be offered to selected trainees including; the opportunity 1) to apply for a Clinical Investigator Development Award (K08) for continued mentoring, 2) to apply for independent grant support, and 3) for those oriented toward a career in transfusion medicine, an opportunity for further training as a junior member of BloodCenter's medical staff. Ultimately, trainees are expected to pursue academic or alternate careers in transfusion medicine, hematology, or closely related fields.
Director:
Karin Hoffmeister, M.D.
Senior Investigator Blood Research Institute
Professor of Biochemistry at Medical College of Wisconsin
Associate Professor of Pediatrics, Harvard Medical School
Email: K12Admin@bcw.edu
Contact:
Christina Daniels
K12 Program Administrator
BloodCenter of Wisconsin
Blood Research Institute
8733 W. Watertown Plank Rd.
Wauwatosa, WI 53226
Phone: (414) 937-6896
Email: Christina.Daniels@BCW.EDU
Website: https://www.translationalglycomics.com
Program Scope and Mission – Translational medicine fosters cross-functional collaborations between researchers and clinicians to facilitate new and precision-driven treatments for individualized therapy. While scientists and clinicians successfully applied this approach to four fundamental building blocks of life (nucleic acids, lipids, proteins and carbohydrates), the science of glycans (carbohydrates) has received the least attention. The diverse functions of glycans contribute to the structural integrity of biomolecules, extracellular matrix formation, signal transduction, protein folding, information exchange between cells, and host-pathogen interactions. Despite their functional diversity and specificity, carbohydrates are commonly associated with weight gain and diabetes while their major contributions to health and disease remain vastly understudied. Furthermore, the use and modulation of glycans has been largely unexplored in therapeutic strategies. There is an urgent need to support and educate glycoscientists concomitantly with the biology of human health and disease, thus enabling clinicians and glycoscientists to recognize medical needs and therapeutic opportunities. To meet these needs, the National Heart, Lung, and Blood Institute (NHLBI) for the first time has offered a K12 Career Development Program in translational glycosciences titled “National Career Development Consortium for Excellence in Glycosciences.”
One of the four national sites is the Blood Research Institute and the Center for Translational Glycomics, BloodCenter of Wisconsin (BCW), in association with the Medical College of Wisconsin (MCW), Roswell Park Comprehensive Cancer Center (Roswell), and Virginia Commonwealth University (VCU). This program, The Medical and Translational GlycOmics Program (Translational GlycO Program), is a multi-institution (Wisconsin, New York and Virginia) program, linking unique and diverse glycoscience expertise with research facilities, major teaching hospitals, blood banking and pharmaceutical education. It is expected that the Translational GlycO Scholars will commit to and pursue a glycoscience based investigation, as it relates to the mission of the NHLBI (heart, blood, lung, and sleep disorders). Training in investigative glycoscience thought processes and experimental tools will be provided through a rigorous program involving hands-on research, didactic coursework, collaboration with experienced scientists in and outside the field, dissemination of knowledge, paper and grant writing activities, and participation in the national K12 consortium. Scholars will become knowledgeable in 1) molecular aspects of glycoscience; 2) experimental research inquiries into functions of glycans; 3) translation of bench research to the bedside; 4) dissemination of research to scientists and the lay public; and 4) writing extramurally funded grant applications. For more information and application processes refer to the K12 Program Website
Director:
Ivor Benjamin, M.D., F.A.H.A., F.A.C.C.
Director, Cardiovascular Center
Professor, Department of Medicine
Froedtert & Medical College of Wisconsin
Email: ibenjamin@mcw.edu
https://www.mcw.edu/Cardiovascular-Center/Research-Labs/Ivor-Benjamin-MD-FAHA-FACC.htm
Contact:
MCW Cardiovascular Center
Medical College of Wisconsin
8701 Watertown Plank Rd.
Milwaukee, WI 53226
(414) 955-5611 | Fax (414) 456-6515
Email: cvc@mcw.edu
Website: https://www.mcw.edu/departments/cardiovascular-center-heart
Program Scope and Mission –
This five year T32 program is one of only six post-doctoral T32 training programs on the Milwaukee Medical Regional Campus. The grant provides up to three-years of training for post-doctoral fellows with an MD, PhD, PharmD, or DO degree (two new slots/year). Forty-six basic scientists and translational investigators serve as mentors in a program that is supported by specific research areas of scientific excellence (“Signature Programs”), a highly-integrated collaborative research environment, and access to an extensive research infrastructure.
This three-year training commitment emphasizes critical components designed to launch/sustain research careers: • Individualized development plans (IDPs), • Personalized multidisciplinary mentoring teams, • Training in core competencies, and • Industry/biotechnology or scientific liaison career options for trainees not pursuing a traditional career in academia. Overall, the ultimate goal of this training program is to train the next generation of cardiovascular scientists, including underrepresented minorities, by incorporating broad-based, personalized, supportive, and rigorous training opportunities. Additional support for trainees is provided by a grant from the A. O. Smith Foundation for the Cardiovascular Center’s A. O. Smith Fellowship Scholars Program. This unique program is designed to support talented cardiovascular researchers and physicians in an innovative educational program that aims to provide mentoring, training, research support, and the necessary resources to overcome the barriers that exist to launching and sustaining a successful research career.
Director:
Mark K. Eskandari, MD, F.A.C.S.
The James S. T. Yao, MD, PhD, Professor of Vascular Surgery
Chief and Program Director, Division of Vascular Surgery
Northwestern University
Feinberg School of Medicine
676 N. St. Clair, #650
Chicago, IL 60611
Contact:
Marsha Blunt, VSSTP Program Coordinator
Telephone: (312) 926-7775
Northwestern Email: marsha.blunt@nm.org
https://www.surgery.northwestern.edu/divisions/vascular/research/scientist-training.html
Program Scope and Mission –
The NIH-funded Vascular Surgery Scientist Training Program at Northwestern University is a two-year mentored research training program designed for surgical residents (MD/DO) in general, cardiac, and vascular surgery interested in vascular biology or vascular biomedical engineering careers. Our goal is to provide a seamless multidisciplinary environment in which the trainee may interact with a diverse group of distinguished research faculty. The T32 mechanism provides a stipend, tuition, fees for coursework, travel funds, and health insurance.
The key to this program is an individualized training plan developed by the mentor and trainee. The unique multidisciplinary environment provides trainees with opportunities to work with mentors from different disciplines. The goal of this program is to match the research interest of the trainee to mentors, coursework, seminars, meetings, and a research plan that will collectively provide the experience necessary to launch a successful career as a physician scientist. Trainees may select one of several tracks of study or a combination of tracks:
• Vascular biology with a basic science or translational emphasis,
• Clinical outcomes/health services research
• Biomedical devices in partnership with the Biomedical Engineering Department
• An integrated program designed by the trainee and his/her mentors.
Trainees who select the clinical outcomes/health services research track will pursue the Master of Science in Health Services and Outcomes Research degree program at NU.
Candidates must hold either an MD or DO degree and must have completed at least two years of clinical training prior to enrolling in the program. Candidates must be U.S. citizens, noncitizen nationals, or have been lawfully admitted for permanent residence at the time of appointment. Minorities and women are encouraged to apply. Applicants will submit a written application along with three letters of recommendation.
Director:
Dr. Vidu Garg
Vidu.Garg@nationwidechildrens.org
and
Dr. Peter Mohler
Contact:
Dr. Brenda Lilly
Brenda.Lilly@nationwidechildrens.org
and
Dr. Vidu Garg
Vidu.Garg@nationwidechildrens.org
Program Scope and Mission – A postdoctoral fellow position is available for the T32 Fellowship Program entitled, “Training in Congenital and Acquired Heart Disease.” The program is jointly hosted by the Research Institute at Nationwide Children’s Hospital and the Dorothy M. Davis Heart and Lung Research Institute at The Ohio State University (PIs: Dr. Vidu Garg and Dr. Peter Mohler).
Eligibility requirements are as follows:
• MD, PhD, MD/PhD, DO, DVM, or PharmD, particularly underrepresented minorities, are encouraged to apply. Applicants will receive stipend (at appropriate NIH stipend guidelines), benefits and tuition support.
• Applicant must be a citizen or a non-citizen national of the United States or have been lawfully admitted for permanent residence at the time of appointment.
• Proposed research must be directly related to aspects of congenital or acquired cardiovascular disease and can be basic, translational, clinical or outcomes research.
• 1 year fellowship that is renewed based upon productivity (for a maximum of 2 years).
• Applicants are required to participate in the T32-developed curriculum (i.e. didactic coursework, seminars and/or journal clubs).
• Applications are scored in 3 areas: trainee qualifications, scientific merit and training potential.
Website: https://omrf.org/programs/cardiovascular-biology-research-program/
The Oklahoma Medical Research Foundation (OMRF) is an independent, nonprofit biomedical research institute dedicated to understanding and developing more effective treatments for human diseases. It is adjacent to the University of Oklahoma Health Sciences Center (OUHSC) in downtown Oklahoma City.
Vascular Research at OMRF: OMRF’s Cardiovascular Biology Research Program investigates fundamental mechanisms involved in cardiovascular and lymphatic development and function, blood coagulation, fibrosis, inflammation, and sepsis. Our scientists integrate their expertise in genetics, biochemistry, molecular biology and physiology in their research. The program houses 11 independent laboratories, which are home to an interactive community of scientists at various career stages. Our labs have exciting training opportunities for motivated graduate students and postdoctoral researchers. Our trainees benefit from OMRF’s outstanding shared resources and collaborative environment, including a vibrant institutional training program for postdoctoral researchers. OMRF is consistently voted a top place to work in Oklahoma and the U.S.
Graduate Student Training: Interested candidates are eligible to pursue research opportunities in our labs after enrolling at the University of Oklahoma Health Sciences Center (OUHSC). The university has graduate training programs for Ph.D., M.S., and M.D./Ph.D. students.
Postdoctoral Training: Qualified candidates can contact the principal investigators in our program to enquire about availability of positions in their labs. Please include a cover letter, CV, and career goals.
Director:
James K. Liao, MD
Harold H. Hines Professor, Committee on Molecular Metabolism and Nutrition
Chief, Department of Medicine – Section of Cardiology
Director, Physician Scientist Development Program
Email: jliao@medicine.bsd.uchicago.edu
https://biomedsciences.uchicago.edu/page/james-liao-md
Contact:
Phetcharat Chen, Administrator
Email: pongusaha@medicine.bsd.uchicago.edu
Website:https://biosciences.uchicago.edu/directory/cardiovascular-sciences-training-grant-t32-hl007381
Program Scope and Mission – The Cardiovascular Training Grant supports both post-doctoral (M.D. and Ph.D.) and pre-doctoral (Ph.D.) students for terms of 2-3 years to work in the laboratories of one of 33 trainers, whose research is in the cardiovascular sciences. The trainers include faculty from Cardiology, Pathology, Internal Medicine, Neurology, Pharmacology and Physiology, and Biochemistry and Molecular Biology. The program emphasizes training in vascular biology, atherosclerosis, cardiac development, cellular electrophysiology, cellular metabolism, cell signaling, gene regulation, and genetic disease.
Director and Contact:
Jeffery D Molkentin, PHD
Children's Hospital Medical Center-Cincinnati
Office of Sponsored Programs
3333 Burnet Avenue, MLC #7030
Cincinnati, OH 45229
Phone: 513-636-3557
Jeff.molkentin@cchmc.org
https://www.cincinnatichildrens.org/research/divisions/m/mcb/labs/molkentin
Program Scope and Mission – The University of Cincinnati and Children’s Hospital is carrying on a proud tradition of excellence in cardiovascular research and mentorship, which began 35 years ago under Dr Arnold Schwartz as one of the longest training programs in cardiovascular. Our current collective 19 faculty has placed 297 of their past trainees into academics over their careers, 154 of whom have run, or currently run independent research programs. The overall scientific emphasis of our training program will continue to build from a basic platform of cardiovascular physiology, cell biology, biochemistry and pharmacology, but will also incorporate the latest approaches in the post genomic era, as well as incorporating clinical and translational approaches. The cardiovascular environment at Cincinnati Children's and the University of Cincinnati is considered one of the very best in the country, with 19 NIH funded faculty (some 49 NIH grants amongst them as PI status), 166 collaborative papers published in 10 years, and the very latest technologies and approaches with outstanding core support. The leadership consists of the co-PIs Drs. Evangelia Kranias and Jeffery D. Molkentin, both of whom have a long standing track record of working closely together (15 years), as well as having excellent mentorship credentials. The training grant funds 3 pre- and 3 postdoctoral trainees. Predocs are selected by the Internal Advisory Committee from a wide pool arising from departmental graduate programs, while postdoctoral candidates are selected based on being accepted into a mentor's laboratory and then passing the screening process by the Internal Advisory Committee and co-PIs. The training program also has an educational core where both pre-docs and post-docs take elective classes in cardiovascular biology, genetics, statistics, grant writing and ethics in research. More importantly, the cardiovascular training faculty at the University of Cincinnati and Children’s Hospital is one of the largest groups in the nation and they incorporate the very latest technologies in the pursuit of their scientific endeavors. Strengths include generation of transgenic and gene-targeted mice, as well as CRISPR-mediated mouse production, in the pursuit of understanding single gene function in complex cardiovascular diseases. Genetics are also employed and the program also has a strong clinical mentorship track for trainees interested in translational science.
mporary and a defined period (2-year) of mentored advanced training and professional development following completion of a doctoral degree program.
PI/Program Director:
Asrar B. Malik PhD
Contact:
Dr. Asrar B. Malik
Director of Center for Lung and Vascular Biology
University of Illinois College of Medicine
Department of Pharmacology
835 South Wolcott Ave, E403 MSB
Chicago, IL 60612
Phone: 312 996-5672
Email: abmalik@uic.edu
http://mcph.uic.edu/lungt32/
Program Scope and Mission – The NIH-funded UIC vascular biology training program is currently in its 25th year, providing comprehensive and cutting-edge training in vascular biology. Research topics include mechanisms of vascular regeneration, the use of stem cell therapies in vascular disease, the critical role of the vasculature in inflammation and immunity, modeling inherited vascular diseases with induced pluripotent stem cells, vascular biology of cancer, mechanisms of thrombosis and novel therapeutic anti-thrombotics. Our post-docs and PhD students are trained in using state-of-the art technologies such as intravital two-photon microscopy, super-resolution microscopy, protein engineering, high throughput small molecule screening or single cell transcriptomics. The training involves acquiring a range of skills from critical thinking and developing an innovative, testable hypothesis to deploying and utilizing relevant methods and technologies. We also offer opportunities to learn how to best communicate ideas and results through presentations and manuscripts. The success of our trainees is evident from their publication records in top tier journals and their current positions in academia and industry.
We have 40 preceptors participating in the training program who exhibit a breadth of scientific expertise ranging from basic cell biology to translational models of vascular disease. The faculty comprises a cohort of exceptionally talented mentors with a commitment to research training, collaboration, and developing careers of young investigators. These trainees and faculty meet regularly at the weekly vascular biology seminar as well as additional departmental seminars with invited speakers, many of whom are renowned leaders in the field of vascular biology. The program has several defining features that:
· contemporary biomedical research training must be underpinned by collaboration that can be local or international,
· research training is driven by fundamental ideas, and
· solving important scientific problems and research training should be such as to provide a variety of opportunities beyond the training phase.
The research training program provides opportunities for exposure to scientific leaders and role models and the intellectual environment of Chicago. It is our view that nurturing curiosity is a fundamental aspect of research training but that it also involves learning to ask important questions and becoming a well-rounded and humane individual.
Co-Director:
Jan Kitajewski, PhD
Email: kitaj@uic.edu
Co-Director:
Kishore Wary, PhD
Email: kkwary@uic.edu
Contact:
Kamil Czarnowski, MPA
Director of Administrative Operations
Physiology and Biophysics
College of Medicine
University of Illinois at Chicago
835 South Wolcott Ave
Room E-231 MSB
Chicago, IL 60612
Phone: 312-996-3836
Email: kczarn4@uic.edu
Web: https://physiology.uic.edu/training/
Program Scope and Mission – The NIH-funded Vascular Biology, Signaling and Therapeutics (VBST) training program is designed to be interdisciplinary, drawing on institutional expertise in four themes: Angiogenesis & Regeneration, Vascular Signaling, Neurovascular Biology and Vascular Therapeutics. VBST is made up of twenty-six (26) mentors, of which nine (9) are physician-scientists. This training program utilizes expertise within and interactions between the themes to train predoctoral and postdoctoral applicants in an integrative fashion.
VBST strives to meet an imperative need to train exceptionally talented and diverse scientists engaged in interdisciplinary vascular research with translational potential. The program’s aims are to assure that trainees understand the human vascular system, and are thereby poised to advance translational opportunities, reduce vascular disease, and bridge the current gaps in knowledge between discovery research, drug development and therapy.
Director and Contact:
Dawood Darbar, MBChB, MD
Email: darbar@uic.edu
Program Scope and Mission – Project Summary Cardiovascular disease (CVD) remains a major cause for significant morbidity and mortality in the U.S. especially in ethnic minorities with their high burden of risk factors. Personalized medicine is a rapidly growing field of healthcare whereby an individual's unique genomic, environmental and clinical background is analyzed to ascertain susceptibility to disease, predict their clinical course and tailor specific therapies. Despite recent advances in CV genomics, our inability to target therapy to underlying mechanisms in individual patients, the failure to translate these scientific discoveries to the bedside care of patients and barriers to the incorporation of ethnic minorities in translational CV research have limited our ability to fulfill the promise of personalized medicine. Furthermore, traditional training programs are no longer able to provide trainees with the requisite skills needed to implement the personalized medicine revolution underway. Thereby, major goals of the Training Program in Personalized Cardiovascular Medicine (TPIPCVM) are to equip trainees to become leaders in CV Genomics and be trained in molecular, cellular, disease and whole animal modeling and clinical and translational approaches to CVD so that this new knowledge can be translated into best evidence-based personalized CV care. We will recruit highly talented and motivated pre- and post-doctoral trainees and provide them with the highest caliber training in CV genomics stemming from existing strengths of our faculty in the Division of Cardiology and our partners at UIC. The 3 Research Focus Groups: 1) Cardiac arrhythmias; 2) Ischemic and non-ischemic cardiomyopathy; and CVD-related metabolic syndrome are highly interrelated with each other and directly linked with the central theme of Personalized CV Genomics. The overarching goal of the TPIPCVM is to train the next generation of CV investigators to create new knowledge and implement into best evidence-based personalized medicine. The TPIPCVM mentors are highly successful physician-scientists/scientists with a proven record of research, mentoring and collaboration who offer superb inter- and multi- disciplinary training opportunities. Major strengths of this training program include: exposure of trainees to an integrated basic science molecular, cellular, and whole patient approach to identify the underlying mechanisms of CVD; the track record of the faculty and their common research interest in Personalized CV Genomics; dedicated training in personalized CV medicine; and the potential to implement scientific discoveries to a diverse and under-represented population of patients cared for at UIC Medical Center. The TPIPCVM sets out to train 2 pre-doctoral and 2 post-doctoral students annually. Collectively, this Training Program offers a unique training experience and fulfills an urgent need for training in personalized CV medicine.
Public Health Relevance
The Training Program In Personalized Cardiovascular Medicine (TPIPCVM) provides support for the training of basic and physician-scientists before and after their doctoral degrees. The central theme of the training program is cardiovascular genomics with a focus on abnormal heart rhythms (arrhythmias), weakened heart muscle (cardiomyopathies) and heart disease related the being overweight (metabolic syndrome) and how we can translate these discoveries to the bedside care of patients. The program will prepare future researchers for the unique challenges associated with treating patients with heart disease in an individualized manner.
Director and Contact:
Martha L. Daviglus, M.D., Ph.D.
Adjunct Professor of Preventive Medicine and Medicine
Executive Director, Institute for Minority Health and Research
Associate Vice Chancellor for Research
Email: daviglus@uic.edu
Phone: 312-413-0739
http://chicago.medicine.uic.edu/research/research-in-chicago/institute-for-minority-health-research/administrative-staff/name/martha-daviglus/
Website: http://chicago.medicine.uic.edu/departments/academic-departments/medicine/research/research-training-programs/
Program Scope and Mission – This Training Program is designed to prepare the next generation of scientists to conduct research in the epidemiology and prevention of cardiovascular disease (CVD) and related chronic diseases in minority populations. Despite decades of research progress, the burden of CVD and related chronic diseases in the United States remains high. Moreover, there are persistent race/ethnic disparities in CVD and other chronic disease outcomes. The goal of this program is to generate a talented and well-trained group of pre- and post-doctoral (MD and PhD) researchers to improve understanding of the etiology and prevention of CVD and related chronic conditions in minority populations and to alleviate race/ethnic disparities in CVD and related chronic disease outcomes.
Director:
Francois M. Abboud, M.D.
Edith King Pearson Chair of Cardiovascular Research
Associate Vice President for Research
Chair Emeritus, Department of Internal Medicine
Founding Director, Francois M. Abboud Cardiovascular Research Center
Professor of Internal Medicine – Cardiovascular Medicine
Professor of Molecular Physiology and Biophysics
Email: Francois-abboud@uiowa.edu
https://medicine.uiowa.edu/internalmedicine/profile/francois-abboud
Contact:
Loretta Bassler
Email: Loretta-bassler@uiowa.edu
Website: https://medicine.uiowa.edu/cardiovascular/research/abboud-cardiovascular-research-center-t-32
Program Scope and Mission – The discovery of the causes of cardiovascular disease and their prevention; the care of the suffering patients and their cure, requires dedicated physicians and scientists to devote their lifelong work to a health mission without which a civilized society would not survive. Such individuals require years of training in medical science beyond their professional degree under the tutelage and mentoring of established senior medical investigators/teachers working in an environment with exceptional intellectual, technical, and physical resources. At the University of Iowa Cardiovascular Research Center, we have provided a world-renowned training center since 1975, have graduated hundreds of scientists, many of whom are national leaders throughout the USA, and aim to continue to do so for future generations with the renewal of federal support that we are applying for and hope to attain.
Contact:
Jordan Shavit, M.D., Ph.D.
Henry and Mala Dorfman Family Professor of Pediatric Hematology/Oncology
Associate Professor of Pediatrics
University of Michigan
jshavit@umich.edu
Website: https://www.shavitlab.org/
Program Scope and Mission – The Boxer Training Program in Molecular and Translational Hematology is designed to prepare physicians and postdoctoral scientists for independent, research-oriented careers in hematology. The program draws on the research interests and expertise of 19 well-funded faculty members in the Departments of Pediatrics, Internal Medicine, Pathology, Pharmacology, Cell and Developmental Biology, Molecular and Integrative Physiology, and Biological Chemistry, the Life Sciences Institute and the Howard Hughes Medical Institute, and the Schools of Engineering and Public Health at the University of Michigan. Active areas include molecular, cellular, and translational research of: 1) the pathophysiology of the immune system; 2) normal and malignant hematopoiesis; 3) hemostasis, thrombosis, and vascular biology; 4) blood and marrow transplantation; and 5) erythrocyte physiology and disease. A Selection/Monitoring Committee will recruit MD, MD/PhD, and PhD trainees with strong academic credentials who desire a scholarly career encompassing hematology teaching and research. MD candidates will have had 3 years of house officer training in Pediatrics or Internal Medicine and a year of clinical training in Pediatric or Adult Hematology/Oncology. PhD candidates will have a major interest in hematology-related research. Trainees spend 2-3 years under supervision of a faculty mentor, developing expertise in posing feasible scientific questions, acquiring skills to answer these questions, and critically evaluating data obtained. During their research training, trainees are continuously mentored and evaluated semiannually by a Mentoring Committee. Trainees present the results of their investigations, participate in discussions of data obtained by their colleagues, and attend relevant research seminars and interact with faculty members in basic and translational sciences. This program will fulfill a critical need to train the next generation of academic hematologists who will bridge the gap between laboratory and clinical research.
Contact:
Daniel Michele, PhD
Professor, Departments of Molecular and Integrative Physiology and Internal Medicine
University of Michigan
North Campus Research Complex
2800 Plymouth Road, Bldg 26, Room 207S
Ann Arbor, MI 48109-2800
Email: dmichele@umich.edu
Website: https://sites.google.com/umich.edu/cvre-t32/home
Program Scope and Mission – Cardiac and vascular diseases remain the leading causes of death worldwide, and the demand for a diversely trained PhD workforce to develop new therapies is expanding. The program goal is to address this deficit in the PhD workforce by teaching the next generation of cardiovascular PhD scientists and engineers how to develop and translate basic research towards applications in clinical medicine. This Predoctoral Training Program includes training on how to conduct preclinical translational research, improve understanding of steps of developing therapies from bench to bedside, and experiential learning in research entrepreneurship. All training is conducted at state of the art facilities of the Frankel Cardiovascular Center laboratories alongside world leading research teams in basic and translational research, clinical research, health services and outcomes research, and multidisciplinary programs.
The Program Features Include:
Basic Cardiovascular Research Training
- Selection of Research Training Mentor & Project and Perform Laboratory Research
- Selection of Clinical Advisor for your Project
- Frontiers in Cardiovascular Sciences Seminar Series
- Research Responsibility and Ethics Training
Training in Pre-Clinical Translational Research
- Pre-clinical Cardiovascular Models, Preclinical Testing and Phenotyping
- Translational Cardiovascular Research Seminars
Training in Research Entrepreneurship
- Research Entrepreneurship Bootcamp
- Entrepreneurship Course
- Experiential Learning in Project Design, Management and Team Science
Fellows are encouraged to explore a variety of additional enrichment activities to supplement the requirements of the training grant.
Director:
Aaron R. Folsom, M.D., M.P.H.
Professor, Division of Epidemiology and Community Health
https://directory.sph.umn.edu/bio/sph-a-z/aaron-folsom
Contact:
Aaron R. Folson, M.D., M.P.H.
1300 S 2nd St
Room 300 West Bank Office Building
Minneapolis, MN 55454
Email: folso001@umn.edu
Website: http://www.sphresearch.umn.edu/epi/cardiovascular-disease-research/
Program Scope and Mission – While the rate of deaths from cardiovascular disease (CVD) has been on the decline, improved survival has resulted in significant new cases and cost to the health care system in our rapidly aging society. Thus the goal of CVD epidemiology is to investigate and promote cardiovascular health, and to prevent and reduce CVD.
Traditionally, cardiovascular disease epidemiology has been concerned with causes of heart disease. In recent years, prevention by modification of lifestyle and behavior have been tested and found very effective. In addition, new methods to detect disease while subclinical have strengthened our studies of antecedent risk factors. Researchers at EpiCH investigate the distribution and causes of CVD and study the influence of:
• high blood cholesterol
• diabetes
• high blood pressure
• blood clotting
• menopause
• genetic variants
• obesity and weight gain
• fat distribution/ patterning They also explore the impact of health behaviors such as:
• smoking
• diet
• physical inactivity
• psychosocial stressors
• education
• geocoding and neighborhoods
Co-Directors:
Prof. Bob Tranquillo
email: tranquillo@umn.edu
and
Prof. Victor Barocas
email: baroc001@umn.edu
website: https://cse.umn.edu/bme/cardiovascular-engineering-training-program
Program Scope and Mission – The proposed T32 training program is designed uniquely to educate, train, and experientially sharpen doctoral students in biomedical engineering, within a multidisciplinary context that specifically engages clinicians and clinician-scientists towards that end. During their participation as trainees in their first two years of predoctoral study in the University of Minnesota (UMN)’s established biomedical engineering graduate program, six trainees per year will interact with a strong training faculty in numerous ways, including these distinctive activities beyond commencing their doctoral research:
- complete the courses Advanced Cardiac Physiology and Anatomy (organized by the leader of UMN-Medtronic Visible Heart Lab collaboration) and Cardiovascular Devices (taught by local cardiovascular device company experts);
- complete a clinical immersion in one of the UMN cardiovascular clinics;
- attend an innovation lecture series (offered through the UMN Medical Devices Center);
- attend monthly clinical focus lunches with invited clinicians presenting specific cardiovascular diseases and associated medical device limitations;
- and attend monthly professional development lunches with invited speakers addressing broad career opportunities including medtech company R&D, FDA, and patent law.
We will recruit a diverse group of trainees, and the program will be reviewed periodically by an advisory committee to ensure its success in all respects. We expect that the resulting multidisciplinary research and perspective of our trainees will enable them to meet the aforementioned demand by driving future technological advancements, either as R&D engineers at cardiovascular device companies, device regulators at federal labs, or as professors leading their own research programs in cardiovascular engineering.
Directors:
Samuel Dudley, MD, PhD
and
Peter Crawford, MD, PhD
Contact:
Elizabeth Gorka
Email: egoldsmi@umn.edu
Program Scope and Mission – This Training Program in Cardiovascular Innovation is designed to teach the scientific and technical skills necessary to develop a novel idea and carry this idea through to proof-of-concept in man. The training program takes unique advantage of the strengths of the Lillehei Heart Institute (LHI), the University of Minnesota Cardiovascular Division, the wider community of translational medicine and entrepreneurship at the University of Minnesota, and the Twin Cities biotech, pharma, and device industries. This application trains basic and clinical scientists in an interdisciplinary environment with the goal of giving them the insight and tools to be able to successfully carry an idea from conception to implementation in man. Therefore, the major goal of this new Training Program is to provide an interdisciplinary research and training environment wherein trainees will be exposed to the continuum of technological development from conceptual idea to testing at the basic, small animal, large animal, and human levels. Trainees will be advantaged by community strengths in basic, translational, and clinical science, training in cardiovascular innovation and entrepreneurship, and industry interactions and mentorship. The combination of scientific and entrepreneurship training is the central innovative feature of this application.
Contact:
John Spertus, MD, MPH
Missouri/Lauer Endowed Chair
Professor, University of Missouri-Kansas City
Clinical Director, Outcomes Research
Saint Luke’s Mid America Heart Institute
MAHIResearch@saintlukesks.org
https://www.saintlukeshealthsystem.org/cardiovascular-outcomes-research-postdoctoral-fellowship
Program Scope and Mission – Applications are invited for a 2-year postdoctoral training program in cardiovascular outcomes research to begin July 1, 2018. This T32 training program, funded by the National Heart Lung and Blood Institute to the University of Missouri-Kansas City (UMKC), is hosted by Saint Luke’s Mid America Heart Institute (SLMAHI) in close collaboration with the University of Kansas.
The Full-Time Training Program offers:
• Advanced seminars of specialized skills for Outcomes Research
• Opportunity to obtain an MS in Bioinformatics with an emphasis in Clinical Research for those without prior formal training in the field
• Multidisciplinary mentorship, individualized to meet the needs of each Fellow
• Hands-on research experiences with access to highly experienced statisticians and numerous databases including multicenter outcome registries (e.g., PREMIER, TRIUMPH, PORTRAIT, PRISM, OPEN CTO, OPTIMUM), clinical trial databases (e.g., PARTNER, FREEDOM, SYNTAX), national quality databases (e.g., ACC’s National Cardiovascular Data Registries, AHA’s National Registry of Cardiopulmonary Resuscitation) and publically available clinical trial and observational data sets.
• Salaried position based on NIH postdoctoral stipend scales
• Insurance benefits, vacation time, tuition (for MS coursework), and funds for travel expenses to professional conference(s)
Director:
Jon Matsumura, MD
Email: tomatsumura@surgery.wisc.edu
Contact:
Sarah Pavao, Program Coordinator
Associate Administrative Program Specialist
Department of Surgery | University of Wisconsin School of Medicine and Public Health
K6/160 CSC | 600 Highland Avenue | Madison, WI 53792-1690
Phone: 608.262.0744
Fax: 608.252.0919
E-mail: pavao@surgery.wisc.edu
http://www.surgery.wisc.edu/education-training/training-for-researchers/uw-vascular-surgery-research-training-program/
Program Scope and Mission – The University of Wisconsin Vascular Surgery Research Training Program is a multidisciplinary and collaborative program that will co-train young physician/surgeons who have chosen to be vascular specialists, along with PhD scientists who have a research interest in vascular disease. This NIH-funded program provides trainees with multiple opportunities for research activities in vascular-related research disciplines in order to foster the development of knowledge, skill, and experience for success in the future academic careers of our trainees. Our goal is to accelerate the performance of basic, translational and clinical research for vascular disease by producing future surgeons, scientists and engineers who will meet the great need for innovation in treatments for the growing population of patients.
Director:
Dr. Anjon Audhya
Molecular and Cellular Pharmacology
School of Medicine and Public Health
5214a Biochemistry
420 Henry Mall
Madison, WI 53706
Phone: (608) 262-3761
Email: audhya@wisc.edu
Contact:
Kristin Cooper, MS
Program Coordinator
Molecular and Cellular Pharmacology
University of Wisconsin-Madison
Mail: Room 1005, 1111 Highland Ave
Office: L5/175
Madison, WI 53705
Phone: (608) 262-9826
Email: kgcooper@wisc.edu
http://molpharm.wisc.edu/
Program Scope and Mission – Pharmacology is the knowledge of the biochemical and physiological actions of drugs, which act on cellular signaling pathways. The molecular basis of cellular signaling and its control by various drugs is a major aspect of modern pharmacology and this aspect is emphasized in the Molecular and Cellular Pharmacology Training Program. The majority of signal transduction pathways still await discovery or at least a thorough molecular characterization. Members of our program employ the whole spectrum of modern biochemical, cell and molecular biological, physiological, and pharmacological methods in a basic research-oriented scientific environment to unravel the many unsolved mysteries underlying cellular regulation and signaling. Certain research initiatives have a translational component, with the goal of applying basic discoveries to developing new therapeutic modalities.
Our program brings together an outstanding group of over 70 dedicated trainers with a focus on cellular signal transduction. Graduates of the program will be well prepared for a career in basic biomedical sciences in academia, industry, and more. We provide a unique training experience for young scientists who want to elucidate basic principles of cellular signal pathways. Detailed knowledge of these pathways is the most important prerequisite for the discovery of new drugs and the treatment of diseases. The members of the Molecular and Cellular Pharmacology Training Program invite you to examine the educational and research opportunities described on our website, and to consider joining this unique and exciting graduate program.
Director:
John P. Sheehan, M.D.
Associate Professor
Email: jps@medicine.wisc.edu
https://www.medicine.wisc.edu/hemonc/sheehanlab
Contact:
John P. Sheehan, MD, Principal Investigator
c/o David Smith
600 Highland Ave. Box: 5669
Madison, WI 53792
Email: dsmith@medicine.wisc.edu
Website: https://www.medicine.wisc.edu/hemonc/researchtoc
Program Scope and Mission – Our grant emphasizes pre-doctoral and post-doctoral training in the areas of vascular biology, and hematopoietic stem cells and malignancy. Vascular biology is critically important for human disease, impacting on basic processes such as inflammation, the immune response, hemostasis, thrombosis, and metastasis.
We have assembled a broad array of expertise in cellular and molecular aspects of hemostasis, extracellular matrix biology, vasculogenesis/angiogenesis, cellular mechanisms of inflammation, the genetics of diabetes, lipoprotein metabolism, and clinical aspects if hemophilic and thrombophilic states. Likewise, hematopoietic stem cells are important to therapeutic approaches in a variety of disease states, and the University of Wisconsin is an internationally recognized leader in embryonic stem cell biology. The participating investigators have expertise in the biology and hematopoietic differentiation of embryonic stem cells, chromatin modifications in hematopoiesis and leukemogenesis, intracellular signaling in myeloma, clinical trials in lymphoma, bone marrow transplantation, and clinical applications of embryonic stem cells in vascular and malignant disease. There is a strong emphasis on providing the multidisciplinary training required to pursue translational research opportunities, and the formal training of clinical investigators. Our training program takes advantage of the Clinical Investigator Preparatory Program (K30 grant) at the University of Wisconsin to provide didactic training in clinical trial design and biostatistics for candidates pursuing translational research projects.
Director:
Jian-Ping Jin, M.D., Ph.D.
Professor & William D. Traitel Endowed Chair
Wayne state University School of Medicine
Department of Physiology
Email: jjin@med.wayne.edu
Contact:
Christine R. Cupps
Program Administrator
Detroit Cardiovascular Training Program
Wayne State University
Department of Physiology
5278 Scott Hall
540 E. Canfield
Detroit, MI 48201
Phone: 313-577-4639
Email: ccupps@med.wayne.edu
Website: http://physiology.med.wayne.edu/dctp
Program Scope and Mission – Cardiovascular disease is a leading cause of mortality in the United States. Understanding the physiology and pathology of the heart and circulation is the foundation for improving the treatment and prevention of cardiovascular diseases. The Detroit Cardiovascular Training Program (DCTP) was the first NIH-supported predoctoral training program in the region to provide research training for PhD graduate students in integrative and translational cardiovascular sciences. This training effort is contributing to the education of a new generation of scientists who will not only pursue cardiovascular research to improve health care, but also strengthen our economic base by innovations that will be translated to medical practice.
The DCTP has assembled an leading group of researchers from multiple departments such has Physiology, Biomedical Engineering, and Pharmaceutical Sciences, who provide expertise and research opportunities to trainees that range from molecular, cellular and organ levels to clinic research. In addition, Wayne State University has an outstanding track record of providing extensive training in the cardiovascular sciences and an exceptional record in the training of minority students in the Detroit metropolitan area, contributing a major role in research education in the region.
Director and Contact:
Jeanne M. Nerbonne, Ph.D.
Email: jnerbonne@wustl.edu
Website: https;//integrativesystemsbiologytraining.wustl.edu
Program Scope and Mission – The goals of the Integrative and Systems Biology of Cardiovascular Disease Training Program in the Center for Cardiovascular Research at Washington University are to provide predoctoral and postdoctoral trainees with: outstanding research opportunities; fundamental education and basic training in cardiovascular physiology, pathophysiology and disease mechanisms; opportunities to be introduced to and to participate in, translational cardiovascular research; and, mentoring to prepare them to be productive, independent scientists, educators and mentors. The critical components and the clear strengths of this Program are the twenty-one (23) participating faculty and the trainees themselves. Another clear strength of this Training Program is the highly interactive and collaborative environment in the Center for Cardiovascular Research, indeed at Washington University in general, which translates to expanded research, education, training and mentoring opportunities for all of our trainees. The participating training faculty derive from seven Departments, and includes nationally and internationally recognized leaders in the three research and training areas of emphasis in this Training Program: 1) Cardiac biology, remodeling and cardiomyopathies; 2) Ion channels, myocardial excitability and arrhythmias; and, 3) Vascular biology, inflammation and coronary disease. The participating faculty are all highly interactive, collaborative, productive, well-funded investigators who are committed to providing the training, experience, resources, intellectual enthusiasm, and mentoring needed to facilitate the scientific and professional development of the Program trainees. In addition, trainees in this Program participate in: a “Core Curriculum in Integrative and Systems Cardiovascular Biology”, with an continuing emphasis on Rigor and Reproducibility and the Responsible Conduct of Research; weekly "Trainees in Cardiovascular Biology" work in progress series; weekly “Cardiovascular Research” seminar series; biannual “Cardiovascular Training Program Distinguished Lectureship”; and “Cardiovascular Research Day”. This Training Program also provides trainees the opportunity to participate in translational cardiovascular research, and has developed and implemented formal and informal mechanisms to guide trainees in the formulation of individualized educational, training and career development plans and for monitoring the progress, professional development and mentoring of each predoctoral and postdoctoral trainee. Formal mechanisms are also in place for evaluating, and evolving as needed, the Training Program itself.
Simply send a description of your program to sharon@navbo.org. Include contact information and links to your web site.
Currently listing programs from Cedars-Sinai Medical Center, Oregon Health and Science University, Stanford University, University of Arizona, University of California, Los Angeles, Unversity of California, San Diego, Unversity of California, San Francisco, University of Colorado, University of Hawai'i, University of New Mexico and the University of Washington
Co-Directors:
Eduardo Marbán, M.D., Ph.D.
Mark Siegel Family Foundation Distinguished Chair and Director of the Heart Institute
Director, Cedars-Sinai Smidt Heart Institute
Professor of Medicine and Physiology
http://bio.csmc.edu/view/5280/Eduardo-Marban.aspx
Joshua I. Goldhaber, M.D.
Dorothy and E. Phillip Lyon Chair in Laser Research
Director, Basic Research Programs
Director, Cardiology Fellowship Program
Associate Director, Cardiac Intensive Care Unit
Director, Division of Applied Cell Biology & Physiology
Professor of Medicine
http://bio.csmc.edu/view/4671/Joshua-I-Goldhaber.aspx
Contact:
Dana Kramer
Email: cshi.training@cshs.org
Website: https://www.cedars-sinai.edu/Education/Graduate-Research-Education/Training/Heart-Institute-NIH-T32-Funded-Training-Program-for-Postdoctoral-Research.aspx
Program Scope and Mission – The objective of The Cedars-Sinai Smidt Heart Institute Institutional Training Program is to provide postdoctoral fellows with the necessary skills to develop independent and productive academic careers in cardiovascular science. We seek to ensure that all our trainees, be they PhDs, MDs, MD/PhDs or equivalent, develop an in-depth knowledge of the basic science underpinning clinically relevant problems in cardiovascular medicine, as well as a comprehensive understanding of rigorous study design, appropriate methodology and expert technical execution of basic and clinical studies. This not only provides clinical investigators with the skills they need to properly test hypotheses generated at the basic science level, but also informs basic scientists about the clinical aspects of disease in order to stimulate clinically relevant state-of-the-art investigations in the laboratory.
Our training program’s areas of research focus include Cardiac Biology, Arrhythmias, Vascular Biology and Atherosclerosis, Regenerative Medicine, Transplant Immunology, Cardiovascular Imaging, Women’s Health, Community Health, Implementation Science, Precision Medicine and Genetics. The Training Program takes full advantage of the unique strengths of Cedars-Sinai Medical Center (CSMC), the largest private teaching hospital west of the Mississippi, which has a longstanding commitment to translational research and to serving the local community. The Cedar Sinai Heart Institute (CSHI) houses the largest adult heart transplant program in the world, performed an NIH-funded first-in-human trial of cardiac-derived stem cell therapy, and has attracted many NIH-funded basic and translational investigators. Some of these share joint appointments in other CSMC units, which include the Regenerative Medicine Institute, Biomedical Imaging Research Institute, and the Departments of Biomedical Sciences, Medicine, and Pathology. Trainees receive an intensive research experience in a focused area of investigation, augmented by a formal curriculum that includes both basic and clinical seminars, instruction in grant and manuscript writing, public speaking, biostatistics and ethics. Several courses are provided by the Department of Biomedical Sciences, the CSMC Clinical Scholars Program, and a multi-campus NIH CTSA-supported Center for Translational Science Institute (CTSI, includes CSMC, UCLA, Harbor-UCLA, and Charles Drew University). The CTSI provides our trainees with privileged access to project seed funds, additional courses in clinical research design, and tools for conducting the entire range of studies from bench to bedside to community. In summary, we have designed a program that provides in-depth training in critical areas of cardiovascular science within an environment that champions translational research and clinical excellence.
Contact:
Nabil J. Alkayed, MD, PhD
James Metcalfe Chair of Cardiovascular Medicine
Professor and Director of Research, Knight Cardiovascular Institute
Oregon Health & Science University
3181 S.W. Sam Jackson Park Road, Portland, Oregon 97239
Mail Code: UHN-2 ; Phone: 503.418.5502
Fax: 503.494.3092
alkayedn@ohsu.edu
Program Scope and Mission – http://www.navbo.info/OHSU2017-18.pdf.
Director:
Christopher Gardner, PhD
Contact:
Alana Koehler, Fellowship Coordinator
Administrative Associate for Christopher Gardner, PhD
Stanford Prevention Research Center
1265 Welch Road, X3C06
Stanford, CA 94305-5411
Voice 650 723 7822
Fax 650 725 6247
Email: alana.koehler@stanford.edu
Program Scope and Mission Postdoctoral Research Fellowship in Chronic Disease Prevention and Control. The Stanford Prevention Research Center, an interdisciplinary research program on the prevention of chronic disease, is seeking MD and PhD applicants for postdoctoral research fellowships for the academic year 2018-2019. Fellows gain direct research experience in cardiovascular disease prevention, community and health psychology, behavioral medicine, intervention methods, clinical epidemiology, research design, and biostatistics.
See also the website for additional details http://prevention.stanford.edu/education/fellowship/training.html
Director:
Ronald Dalman, M.D.
Chidester Professor of Surgery
rld@stanford.edu
https://med.stanford.edu/profiles/ronald-dalman
Contact:
David L. M. Preston, M.A.
Cardiovascular Institute Program Manager
Cardiovascular Institute
265 Campus Drive, G1120; MC-5454
Stanford, CA 94305
(650) 725-7964
preston@stanford.edu
http://med.stanford.edu/cvi/education/cvi_fellowship_training_program.html
Program Scope and Mission - This program trains a total of six fellows over two years in the following areas of vascular medicine & research: Vascular Reactivity & Thrombosis, Vascular Regeneration & Development, Metabolic or Lifestyle Influences on Vascular Outcomes, Proteomic Markers & Genetic Determinants of Vascular Disease, Gender & Ethnicity Differences in Vascular Disease, and Vascular Bioengineering. Twenty-nine faculty mentors from eighteen different departments within the School of Medicine and the University provide a variety of angles from which to address fundamental questions about vascular disease. A structured curriculum, well-defined mentorship, and both internal and external evaluations ensure that fellows receive training in both research and career development to prepare them for independent careers. All fellows undergo a minimum two-year training period, with strong encouragement to submit individual research proposals (NRSA and AHA) for the following year(s). Support for a second year is conditional on evidence of research progress. At times a third year is offered for the transition to independence. It is mandatory that in Year 1 the trainee and mentor will outline a career plan for transition to independence, which may include grant preparations for funding through a K08 mechanism or application to the existing K12.
Contact:
Joseph Wu, MD, PhD
Stanford University School of Medicine
ProfessorDirector, Stanford Cardiovascular Institute
Simon H. Stertzer, MD Professor of Medicine & Radiology
Lorry I. Lokey Stem Cell Research Building
265 Campus Drive, Rm G1120B
Stanford, CA 94305-5454
Ph: 650-736-2246
Fax: 650-736-0234
Email: joewu@stanford.edu
CVI Website: http://med.stanford.edu/cvi.html
Program Scope and Mission – The Multi-Disciplinary Training Program in Cardiovascular Imaging at Stanford is funded by the National Institute of Biomedical Imaging and Bioengineering of the National Institutes of Health. The program is designed to train the next generation of CV imaging investigators by exposing them to three complementary areas – clinical, engineering, and molecular imaging. With the impact of cardiovascular disease on US and world health and the rapid advances in imaging technologies and cardiovascular biology, it is critical that fellows be provided a broad, multi-disciplinary, and collaborative training program to foster their ability to translate CV imaging research into clinical application. Mentors from the Schools of Medicine and Engineering, including Cardiovascular Medicine, Radiology, Molecular Imaging, Electrical Engineering, and Bioengineering are available. For more details: http://med.stanford.edu/cvi/education/cardiovascular-imaging-t32.html
Director:
Jennifer K. Barton, Ph.D.
Director, BIO5 Institute
Professor, Biomedical Engineering
Professor, Optical Sciences
Professor, Agricultural-Biosystems Engineering
Professor, BIO5 Institute
http://bme.arizona.edu/jennifer-barton
Contact:
Dr. Jennifer K. Barton
Email: barton@email.arizona.edu
Website: http://bme.arizona.edu/cardiovascular-biomedical-engineering-training-grant
Program Scope and Mission – The Cardiovascular Biomedical Engineering training program is dedicated to training pre-doctoral students in both biological and engineering disciplines focusing on cardiovascular health to meet the demands of a growing biomedical engineering field.
This program takes advantage of the UA Department of Biomedical Engineering faculty's, and the Arizona industrial community's strong expertise in bioengineering and cardiovascular biology. Areas of expertise include biomechanics, biomaterials, optics, molecular genetics, vascular physiology, imaging, tissue engineering, genetic engineering and biocomputing.
Director:
Reza Ardehali, M.D., Ph.D.
Associate Professor of Medicine
Associate Chief of Cardiology, Regenerative Medicine
Advanced Heart Failure, Mechanical Circulatory Support and Transplantation
Division of Cardiology
Broad Stem Cell Research Center
UCLA School of Medicine
675 Charles E. Young Drive S. Rm 3780
Los Angeles, CA 90095
Email: rardehali@mednet.ucla.edu
Website: https://vbtg.mcdb.ucla.edu/
Contact:
Nikki Jobanputra
Sr. Admin Analyst
Division of Cardiology
Broad Stem Cell Research Center
UCLA School of Medicine
Phone: 310-825-2554
Email: NJobanputra@mednet.ucla.edu
Program Scope and Mission - The main objective of the Vascular Biology Training Program is to develop the next generation of cardiovascular biologists. The program places a strong emphasis on creativity, networking and self-motivation to develop independent scientists who will make significant contributions to biomedical research and be an asset to the institutions and communities they serve.
To achieve these goals, we have developed a strong mentorship approach, novel didactic components and incorporated high exposure to medicine. UCLA houses a tremendous resource of interdisciplinary groups whose research focuses in vascular biology. The group includes 27 laboratories that currently offer training to 124 graduate students and postdoctoral fellows. It is this community that constitutes the pillars of a unique training program for the next generation of investigators in this area of research. The Program is funded by a grant from the NHLBI that supports pre- and post-doctoral trainees for three and two years respectively. The program also features a highly interactive seminar series with outside speakers and several seminar venues for discussion of science by trainees and UCLA investigators. We invite you to drive through the website and get to learn more about our program and recent accomplishments.
Director:
Matthew A. Allison, MD, MPH, FAHA
University of California San Diego
Professor and Interim Chief
Division of Preventive Medicine
Department of Family Medicine and Public Health
9500 Gilman Drive, Mailcode 0965
La Jolla, CA 92093-0965
Phone: 858-642-3289
Fax: 858-822-7662
mallison@ucsd.edu
Contact:
Nova Barkley, T32 coordinator
9500 Gillman Drive, MC 0607
La Jolla, CA 92093-0607
nsbarkley@ucsd.edu
Program Scope and Mission – http://cvdepit32.ucsd.edu.
Director and Contact:
Andrew D. McCulloch, Ph.D.
UC San Diego
Department of Bioengineering
9500 Gilman Ave. MC0412
La Jolla, CA 92093-0412
Office: 858-534-2547
Fax: 858-534-5722
amcculloch@ucsd.edu
Program Scope and Mission – The aim of this program is to train pre-doctoral bioengineering graduate students to apply quantitative bioengineering approaches to study integrative cardiac, vascular and blood physiology and pathophysiology and to work with physicians on developing novel technologies for therapy and diagnosis of cardiovascular diseases. Trainees learn how to conduct interdisciplinary research by integrating: (a) the engineering and biomedical sciences; (b) across physical scales of biological structure from genes and molecules to tissues and organ-systems; (c) across interacting physiological systems and subsystems; and (d) basic research with technology innovation for clinical applications. Our goal is to train the next generation of bioengineering scientists to be leaders in innovative cardiovascular research and technology development to advance healthcare delivery and improve health outcomes. The program is especially well known for its leadership in systems biology, regenerative medicine and multi-scale bioengineering. Graduates have gone on to become leaders in research, industry and academia including department chairs of top programs.
Director:
Mark Howard Ginsberg, M.D.
Distinguished Professor, School of Medicine
Email: mhginsberg@ucsd.edu
Contact:
MaryAnn Klima
Program Coordinator
9500 Gilman Drive, MC0726
La Jolla, CA 92093
858-822-6432
Email: mklima@ucsd.edu
Website: https://medschool.ucsd.edu/som/medicine/divisions/hem-onc/research/Pages/research-fellowship.aspx
Program Scope and Mission – Arterial thrombosis is frequently the proximate cause of death and morbidity in cardiovascular diseases. These diseases are the leading cause of death in the Western World. Formed elements of the blood and cells of the vessel wall play central roles in arterial thrombosis and in the arrest of bleeding. We have begun an interdisciplinary training program for postdoctoral scientists in the area of blood cells in hemostasis and thrombosis, based in the Division of Hematology-Oncology, to be a centerpiece in an Initiative in Vascular Biology at the University of California San Diego, La Jolla Campus.
Each faculty mentor is an internationally recognized investigator in the development and functioning of the cells that mediate thrombosis and has a strong track record of peer-reviewed research support and of training. The faculty has interacted extensively through the mechanisms of collaboration and through two program projects focused on Vascular Biology and Hemostasis-thrombosis. The interdisciplinary nature of the program is established by faculty primary appointments in six University departments including Cellular and Molecular Medicine, Biology, Pathology, Pharmacology, Physics and Medicine. The core of the program is through performance research in faculty laboratories spanning the disciplines of signal transduction, gene regulation, hematopoiesis, angiogenesis, and the molecular and cell biology of cells of the blood and vessel wall. The practical training will be complemented by didactic coursework in the conduct of research and in the writing of scientific manuscripts and grant applications. Furthermore, the trainees will attend a weekly conference in Atherosclerosis, Thrombosis, and Vascular Biology and will have the opportunity to participate in didactic hematology-oncology translational research conferences and in elective coursework offered throughout UC San Diego. This training program provides a unique interdisciplinary educational opportunity to mentor outstanding scientists for research careers in the cellular basis of hemostasis and thrombosis and will form the only active training program at UC San Diego directly devoted to this health-related field.
Director:
K. Mark Ansel, PhD
Contact:
K. Mark Ansel, Ph.D.
Associate Professor, UCSF Department of Microbiology and Immunology
Investigator, Sandler Asthma Basic Research Center
Director, Biomedical Sciences Graduate Program
513 Parnassus Avenue, Box 0414, HSE-1001E
San Francisco, CA 94143-0414
Office: (415) 476-5368
Lab: (415) 476-5373
Fax: (415) 502-4995
Email: Mark.Ansel@ucsf.edu
Website: http://ansel.ucsf.edu
http://sabre.ucsf.edu/faculty/mark_ansel.html
Program Scope and Mission The Biomedical Sciences (BMS) Graduate Program at UCSF provides students with a wide range of opportunities for their development as researchers that investigate the function of tissue and organ systems in development, physiology and disease. The BMS program’s curriculum provides a foundation in molecular biology, biochemistry, cell biology and the investigation of human biology and disease, and is customized to thematic areas through innovative mini-courses, research rotations, thematic retreats, seminars and other events. Vascular & Cardiac Biology is one of the BMS program's major themes, with over 25 dedicated faculty that are world renowned experts in their respective fields. The program provides in depth interaction and access to the Cardiovascular Institute (CVRI) and the Gladstone Institute of Cardiovascular Disease, together comprising over 100 faculty members investigating a wide spectrum of basic science to disease-focused and patient-based research in cardiovascular biology and disease, as well as world-class core facilities, scientific seminars and research retreats.
Director:
Judith Hellman, MD
Contact:
Claire Harmon
Research Administration Manager
Department of Anesthesia & Perioperative Care
3333 California Street, Suite 290
San Francisco, CA 94118
Phone: 415-476-4762
Fax: 415-514-0500
Email: claire.harmon@ucsf.edu
Website: https://anesthesia.ucsf.edu/nih-t32-postdoctoral-research-fellowship
Program Scope and Mission The primary goal of the program is to provide rigorous training in the fundamentals and techniques of conducting research in areas of concern to clinical anesthesiology and the larger practice of medicine. The Vascular Biology and Bioengineering Track hosts faculty mentors from the Departments of Anesthesia, Biochemistry and Biophysics, Bioengineering, Cellular and Molecular Pharmacology, Medicine, Neurosurgery, Radiology & Biomedical Imaging, and Surgery. Among the broad range of topics studied are AVMs, stroke, vascular aneurysms, drug delivery across the blood brain barrier, spinal cord injury and repair, G-protein coupled receptors, PPARs, thrombosis, novel bioengineered therapeutic antibody development and biomedical imaging. Additional program tracks include Critical Care; Genomics, Outcomes Research and Bioinformatics; and Neuroscience, Pain and Addiction. Funded by the NIH/NIGMS since 1995, the T32 program supports 2 to 3-year trainee appointments, dependent on sufficient trainee progress. Applicants should be MD or MD/PhD scientists, and must be United States citizens, permanent residents or non-citizen nationals. UCSF has an exceptional commitment to excellence and diversity. We welcome all qualified applications and particularly encourage applications from members of underrepresented groups in the sciences, including underrepresented minorities, veterans, and individuals with disabilities. UCSF offers reasonable accommodations for qualified individuals with disabilities. If you are a person with a disability who would like to discuss potential accommodations or engage in a confidential conversation, please contact Disability Management Services at 415-476-2621. Applications are accepted on a continuous basis. For more information and application instructions, contact Claire Harmon at the address above, or visit the program website.
Director:
Kurt R. Stenmark, MD
Professor of Pediatrics and Medicine
Division Head, Pediatric Critical Care Medicine
Director, Developmental Lung Biology and
Cardiovascular Pulmonary Research Laboratories
Email: Kurt.Stenmark@UCDenver.edu
http://www.ucdenver.edu/academics/colleges/medicalschool/departments/medicine/cvp/faculty/Pages/Stenmark.aspx
Contact:
Marcia McGowan
Program Assistant
303-724-5620
Marcia.Mcgowan@ucdenver.edu
or
Andy Poczobutt
Administrator, CVP Research
303-724-3683
Andy.Poczobutt@ucdenver.edu
Website: https://www.childrenscolorado.org/pediatric-innovation/research/cardiopulmonary-and-vascular-biology/
Program Scope and Mission The Cardiopulmonary and Vascular Biology Research Lab’s emphasis area integrates several well-established and successful programs and laboratories that utilize multidisciplinary approaches towards developing a greater understanding of basic mechanisms and therapies for the treatment of diverse cardiac, pulmonary and vascular diseases in newborns, infants and children.
The overall purpose of this group is to promote basic and translational research and to develop and apply novel strategies that will enhance outcomes of children with cardiopulmonary and vascular disorders. Key goals are to facilitate and co-ordinate new program development; provide an “academic home” that will create an environment to enhance mentorship, training and career development opportunities for students, residents, fellows and faculty; establish critical core laboratories to enhance patient- and laboratory-oriented research; expand educational opportunities through integrative seminars, courses and symposia; and to more effectively link investigators from diverse disciplines to encourage further development of novel programs based on principles of “team science.” This group incorporates strengths from current programs that link clinical care, clinical research, laboratory research, education and training. Current themes of ongoing clinical and laboratory research include: basic mechanisms of angiogenesis and vascular development; the influence of vascular growth on lung structure; epigenetic mechanisms of pulmonary vascular disease; the pathobiology of pulmonary hypertension, including vascular inflammation; roles of progenitor cells in vascular development, disease and therapies; novel assessments of right ventricular function, especially in the setting of pulmonary hypertension; the epidemiology and natural history of pulmonary vascular disease in preterm infants; clinical response to drug therapy in chronic pulmonary hypertension; and the development of novel vascular therapies to promote fetal health and prevent premature birth.
Contact:
Dr. Ralph Shohet
Email: shohet@hawaii.edu
or
Dr. Michelle Tallquist
Email: Michelle.tallquist@hawaii.edu
Center for Cardiovascular Research
John A. Burns School of Medicine
651 Ilalo Street, BSB 311
Honolulu, HI 96813
Website: https://sites.google.com/site/ccrheart
Program Scope and Mission The Training in Cardiovascular Research program is an NHLBI funded T32 grant in the Center for Cardiovascular Research at the University of Hawaii. The goal is to provide predoctoral and postdoctoral trainees with a rigorous background in cardiovascular science and techniques that will enable continued success as independent, productive, and innovative researchers. At our new medical campus on the shores of Honolulu, fellows will investigate advanced topics in cardiovascular biology within modern laboratories and with use of state-of-the-art cores. The program consists of 19 University of Hawaii investigators and an additional 10 faculty from the Cardiovascular Institute at Stanford. The training program is designed to meet individual needs but has a common core focused on a comprehensive understanding of cardiovascular science including methodology, anatomy, physiology, and molecular biology. Highlights of the program include a structured mentor program, external project review, and a cardiovascular specific curriculum including journal clubs, problem based learning, and grant writing. Appointments are 1-2 years dependent on continued progress. All fellows are encouraged to obtain independent funding, and many past trainees have been successful in procuring their own fellowships. Applications are restricted to U.S. citizens or permanent residents. For more information, please contact the Program Deputy Director at the address above.
Contact:
Thomas C. Resta, PhD
Professor and CRTP Director
Vascular Physiology Group
Dept. of Cell Biology and Physiology
MSC08 4750
1 University of New Mexico
Albuquerque, NM 87131-0001
Phone: 505-272-8822
Email: tresta@salud.unm.edu
Home Page: http://cbp.unm.edu/faculty-profiles/resta.html
Website: https://hsc.unm.edu/research/brep/graduate/bsgp/crtp.html
Program Scope and Mission – The Cardiovascular Research Training Program (CRTP) at the University of New Mexico (UNM) Health Sciences Center (HSC) is funded by a T32 grant from the NIH National Heart Lung and Blood Institute (NHLBI). The goal of the CRTP is to provide exceptional pre- and post-doctoral trainees a broad, multidisciplinary background in cardiovascular and pulmonary research with integration between basic and clinical sciences. The CRTP partners with the interdisciplinary Biomedical Sciences Graduate Program (BSGP; http://hsc.unm.edu/research/BREP/graduate/bsgp/index.html) at the UNM HSC. This non-departmental program provides training for PhD students in biomedical sciences in the first year followed by in-depth training in the chosen discipline in subsequent years. A training program with a concentration in cardiovascular physiology is available for all predoctoral CRTP trainees in the BSGP. The CRTP T32 provides an NIH level stipend, and allowances for tuition and fees, health insurance, training-related expenses, and travel to scientific meetings. Appointments are 2-3 years for predoctoral students and 2 years for postdoctoral trainees, with subsequent support provided by individual training fellowships or mentored career awards. Applications are restricted to U.S. citizens or permanent residents. For more information and program application instructions, please contact the CRTP Program Director, Dr. Thomas Resta, at the address below.
Director and Contact:
Michael Regnier, PhD
Washington Research Foundation Professor of Bioengineering
Associate for Research, Department of Bioengineering
University of Washington
Seattle, WA 98109
Ph: 206-221-0504
Email: mregnier@uw.edu
http://blogs.uw.edu/bctg/
Program Scope and Mission – The Bioengineering Cardiovascular Training Grant (BCTG) program provides an opportunity for predoctoral students interested in cardiovascular science and engineering to receive training support for their research under the guidance of excellent mentors. The program will simultaneously enrich the trainee’s research and strengthen the future of cardiovascular-related research and technology development in the United States.
The BCTG program is directed by Dr. Michael Regnier and a Steering Committee that selects trainees and monitors their training progress. Training support is usually provided for 2 years. Cardiovascular based research projects that involve collaboration between at least two research laboratories will be preferentially considered.
Participating departments include: Bioengineering, Biology, Chemical Engineering, Mechanical Engineering, Pathology, and Physiology & Biophysics. Predoctoral students from other departments may be considered. Students are eligible after being accepted into a laboratory and supported by the faculty mentor for at least one quarter. There are three main components of the training program:
1. Research in the laboratory of a BCTG faculty mentor on some aspect of cardiovascular physiology, pathology, development of therapeutic treatment, diagnostics and/or imaging.
2. A didactic component that includes a specialized course (Cardiac Bioengineering), a clinical cardiac imaging preceptorship, a seminar series that provides both broad-based knowledge and advanced concepts in focused areas, and a monthly journal club. Trainees with identified weaknesses in mathematics, engineering and/or integrative physiology will be strongly encouraged to do additional didactic training.
3. Communication and professional skills training by participation in seminar series, trainee seminars, and scientific writing programs. Emphasis is placed on career development, public speaking, manuscript preparation and writing fellowships or grant proposals (NIH, AHA, NSF, etc.) at the end of the training period.
Director and Contact:
Karin Bornfeldt, PhD
Professor of Medicine, Division of Metabolism, Endocrinology and Nutrition
Associate Director, Diabetes and Obesity Center of Excellence
Deputy Director, Diabetes Research Center
University of Washington Medicine Diabetes Institute
UW Medicine Research
850 Republican Street, Box 358055
Seattle, WA 98109-4725
Email: bornf@uw.edu
Website: >https://endocrinology.uw.edu/education/
Program Scope and Mission Over-nutrition and obesity are major contributors to the cardiovascular disease epidemic in the United States and worldwide. A major reason for the increase in cardiovascular disease is the increasing prevalence of obesity in both adults and children. The rationale for the T32 Nutrition, Obesity and Atherosclerosis Training Program is to train new generations of postdoctoral MD clinicians and PhD scientists to tackle these problems, taking advantage of the broad interdisciplinary environment at the University of Washington.
The Nutrition, Obesity and Atherosclerosis Training Program’s overall goal is to provide a highly qualified and diverse group of postdoctoral MD clinicians and PhD scientists with the research skills they need to become fully independent biomedical investigators. The research supported by this training program centers on five themes, all related to increased risk of cardiovascular disease. The areas of focus are: i) Central obesity and its relationship to nutrition, dyslipidemia, and other cardiovascular risk factors. This theme includes both basic science and clinical studies of the mechanisms responsible for inflammation and other components of the metabolic syndrome, particularly central obesity. ii) Dyslipidemia and atherosclerosis. This theme includes studies of mechanisms, disorders, and other factors that lead to dyslipidemia, including the metabolic syndrome and diabetes. Mechanisms by which dyslipidemia influences events in the artery wall is an additional component. iii) Pathogenesis of atherosclerosis. This research investigates the pathogenesis of atherosclerosis, using isolated vascular cells and genetically engineered mice. Mouse models that overproduce or are deficient in proteins that modulate lipoprotein profiles are frequently studied. iv) Immunity in cardiovascular disease. This newly added theme studies the interrelationship among immunity, nutritional factors, obesity, and atherosclerosis both in humans and mouse models. v) Genetic and nutritional factors in cardiovascular disease. Several genetic and nutritional factors, including dietary lipids, contribute to the pathogenesis of atherosclerosis and are important in lipid disorders and inflammation. Both basic and clinical studies of the mechanisms by which genetic and nutritional factors play a role in cardiovascular disease support this theme. All of these are strong areas for both basic science and translational research emphasis at the University of Washington. In addition, each area offers our fellows numerous opportunities to acquire the multidisciplinary skills and knowledge that are essential for success in biomedical research. These areas were also chosen because they offer particularly ripe opportunities for integrating basic science and clinical medicine. This integration is essential for ensuring that today’s basic discoveries are translated into tomorrow’s clinical trials and therapies.
Simply send a description of your program to sharon@navbo.org. Include contact information and links to your web site.